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Sarcopenia, the loss of skeletal muscle mass and function, can have serious 
consequences for health and quality of life. With increasing life expectancy and an 
ageing population, the problem of sarcopenia as a public health issue continues to 
grow. Resistance exercise and protein ingestion are two of the main drivers of 
anabolism, and may potentially be targets for interventions to alleviate the effects of 
sarcopenia. 
In Chapter 2 the existing literature was systematically reviewed to determine whether 
the effects of resistance exercise training (RET), which is known to improve muscle 
related outcomes in older adults, can be augmented by the addition of a protein 
supplement in adults aged ≥70 years. Contrary to previous reviews, evidence from 15 
studies (n = 917 participants) indicated no evidence of an effect of supplementation. 
Chapter 3 examined the effects of timing and distribution of protein intake on older 
muscle, again using a systematic review. The identification of just six eligible studies 
(n = 135 participants) indicate a lack of data in this area, although evidence from two 
studies investigating daily protein distributions suggested a significant effect in favour 
of a skewed distribution. 
There is a saturable dose-response relationship between protein intake and muscle 
protein synthesis (MPS) which is thought to plateau at a protein dose of 0.4 g.kg-1 in 
older adults. It is suggested that the distribution of daily protein intake may be 
optimised by considering this threshold; a distribution in which the protein content of 
each of the three daily meals reaches this threshold would theoretically stimulate 
greater MPS than other distributions. The aim of Chapter 4 was to analysis habitual 





protein intake (1.14 g.kg-1.day-1) was adequate according to recommendations, 
however per meal intake data revealed that protein content failed to reach 0.4 g.kg-
1.day-1 in at least two out of three daily meals for 79% of participants. Dietary protein 
distribution was identified as an area with potential for improvement, and therefore a 
target for intervention. 
Chapter 5 reports the results of an intervention study, comparing the effects of even 
and uneven protein distribution diets alongside RET over two weeks, in women aged 
≥65 years. Muscle biopsy and saliva samples were taken and participants consumed 
150ml deuterated water, to measure myofibrillar muscle protein synthesis (MPS). 
Twelve participants (mean age 72.7 years) were recruited, and assigned to consume 
either an even or an uneven protein distribution for two weeks, and both groups 
completed unilateral RET throughout. There was no significant difference in MPS 
between the even and uneven diets in the trained leg (1.02 (0.30) %.day-1 vs 1.16 
(0.26) %.day-1) or the untrained leg (1.05 (0.24) vs 1.17 (0.29) %.day-1). Knee-
extension strength increased by 31 (14) % in the trained leg and 18 (18)% in the 
untrained leg, with no effect of distribution. 
These results do not support the theory of an optimal protein distribution based on 
the maximal MPS threshold dose. However, it is suggested that there is scope for 











I would first like to say a huge thank you to my supervisor, Dr Carolyn Greig, for 
guidance throughout the PhD, and for constant patience and encouragement. I would 
also like to thank my other supervisors, Prof Ken Smith, Prof Philip Atherton, and Dr 
Alison Rushton for their help and advice. Thanks also to Dr Matt Brook and Dr Joe 
Bass for all their help with the lab work. 
I am grateful to the nurses from the Clinical Research Facility at the Queen Elizabeth 
Hospital for their support with the intervention study. I am indebted to all the 
volunteers who gave up their time to participate in my studies, without whom this 
wouldn’t have been possible. 
I would like to acknowledge the valuable contributions of Tim Riviere and Emily Cook 
to the diet and physical activity data analysis in Chapter 4, as well as Prof Janice 
Thompson for her advice. 
Last, and by no means least, I would like to say a special thank you to my family. To 
my husband and my parents, I am forever grateful for your patience and seemingly 
endless positivity which have kept me smiling. 












Thomas DK, Quinn MA, Saunders DH, Greig CA. Protein Supplementation Does Not 
Significantly Augment the Effects of Resistance Exercise Training in Older Adults: A 
Systematic Review. J Am Med Dir Assoc. 2016 Oct 1;17(10):959.e1-9 
- Chapter 2 
- Contributions: conducted literature searches, extracted data, conducted data 
analysis 
Cardon-Thomas DK, Riviere T, Tieges Z, Greig CA. Dietary Protein in Older Adults: 
Adequate Daily Intake but Potential for Improved Distribution. Nutrients. 2017 Feb 
23;9(3) 
- Chapter 4 
- Contributions: conceived the study, collected the data, completed food diary 






















1-RM   1-repetition maximum 
4EBP    4E-binding protein 
AA   amino acid 
ADL   activities of daily living 
AMDR   Acceptable Macronutrient Distribution Range 
ANOVA  analysis of variance 
ASMM  appendicular skeletal muscle mass 
BCM   body cell mass 
BIS   bioelectrical impedance spectroscopy 
CSA   cross sectional area  
CT   computed tomography 
CV   coefficient of variation 
D or 2H  deuterium (2H or D)  
D2O   deuterium oxide 
DXA    dual energy X-ray absorptiometry 
EAA    essential amino acid 
eIF4G/A/B   eukaryotic initiation factors 4 G/A/B 
EWGSOP   European Working Group on Sarcopenia in Older People 
FFM   fat free mass 
FM   fat mass 
FOPANU   Frail Older People - Activity and Nutrition Study in Umeå 
FSR    fractional synthesis rate 
g.kg-1.day-1  grams of protein per kilogram of body weight per day 
IGF-1   insulin-like growth factor 1 





LTM   lean tissue mass  
MET   metabolic equivalent 
MM   muscle mass 
MMSE  Mini Mental State Examination 
MPB   muscle protein breakdown 
MPE   mole percent excess 
MPS   muscle protein synthesis  
mTOR  mammalian target of rapamycin 
MVC   maximum voluntary contraction 
NEAA   non-essential amino acids 
NHANES  National Health and Nutrition Examination Survey 
PEDro  Physiotherapy Evidence Database 
POMA  Performance Oriented Mobility Assessment; 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-     
Analyses 
p70S6K1  ribosomal protein S6 kinase 
RDA   recommended daily allowance 
RE   resistance exercise 
RET   resistance exercise training 
RPS6   ribosomal protein S6 
SD   standard deviation 
SPPB   Short Physical Performance Battery 
TUG   timed up and go 
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1. GENERAL INTRODUCTION 
1.1 Sarcopenia 
 1.1.1 Definition 
Sarcopenia is defined as the age-related decline of skeletal muscle mass and 
function [1], recently recognised as a disease entity by the Centre for Disease 
Control and Prevention (ICD‐10‐CM (M62.84)). The rate of loss of muscle mass has 
been estimated as 0.47% and 0.37% per year in men and women respectively. Loss 
of muscle strength is more rapid at a rate of 2-4% per year [2]. 
As well as describing the process of muscle decline, individuals may also be 
diagnosed as sarcopenic using muscle mass cut-off points. Sarcopenia has 
previously been defined as having appendicular skeletal muscle mass which is more 
than two standard deviations below the average of a healthy young reference 
population [3]. More recently, the European Working Group on Sarcopenia in Older 
People (EWGSOP) has developed an algorithm to define sarcopenia in adults aged 
>65 years, which again includes low muscle mass, in combination with low muscle 
function identified as low gait speed and/or low grip strength [4]. 
 1.1.2 Prevalence 
As an ageing condition, the problem of sarcopenia is growing as the population ages. 
Data from the Office for National Statistics show an increase in the proportion of the 
UK population aged ≥65 years from 15.9% in 2006 to 18% in 2016 [5]; with the total 
UK population also growing, this translates into an increase of over 2 million 





increases in the coming years, predicting that the ≥65 age group will make up 24.7% 
of the population by 2046, and that the ≥85 age group will double in numbers [6]. 
These changes in population age structure are reflective of increases in life 
expectancy. There is a discrepancy between life expectancy and healthy life 
expectancy, with estimates of just 80% and 77% of total lifetime spent in ‘good’ 
health for men and women respectively, and changes in health life expectancy failing 
to match those of life expectancy [7]. Estimates of prevalence of sarcopenia vary by 
population and according the criteria used to define sarcopenia. Analysis of predicted 
appendicular skeletal muscle mass relative to younger reference data from the New 
Mexico Elder Health Survey estimated prevalence to be 13-24% in 50-70 year olds, 
increasing to more than 50% in the over 80s [3]. UK data from the Hertfordshire 
Sarcopenia Study (n = 103, mean age 73 years) and the Hertfordshire Cohort Study 
(n = 1787, mean age 67 years) analysed using the EWGSOP definition reported 
prevalence between 5-8%  [8]. 
 1.1.3 Consequences 
Sarcopenia has a range of consequences, both on a personal and societal level. 
Decline in muscle function impacts upon overall functional ability, which can impair a 
person’s ability to complete activities of daily living such as walking and carrying  [9, 
10], making it more difficult to maintain physical independence. Hence, sarcopenia 
increases the likelihood of developing disability in older age; a study of sarcopenia 
and disability incidence in a study of 5036 men and women aged >65 indicated a 
79% greater likelihood of disability at baseline in those with severe sarcopenia 
compared with normal muscle mass, and 27% greater chance of developing disability 





of falls, as the likelihood of falls has been shown to be twice as likely in men with 
sarcopenia [12], and low muscle density and function increase the likelihood of being 
hospitalised by ,15% and 70% respectively [13]. Furthermore, once hospitalised,  a 
study of infection following hospitalisation has shown twice the risk in patients who 
were sarcopenic upon admission [14], and hospital stays are typically longer, with 
one study of 432 patients indicating a mean stay of 13.4 days in sarcopenic patients 
compared with 9.4 days for those without sarcopenia [15]. It is clear that sarcopenia 
can have significant effects on daily living and general health, and may greatly 
decrease quality of life. 
The impact on society of this spiral of declining physical function and health takes the 
form of a significant financial burden, as a result of increased living assistance and 
healthcare requirements. It was estimated that $18.5 billion of the US healthcare 
expenditure in 2000 could be attributed to sarcopenia and related conditions, 
accounting for 1.5% of total expenditure [16]. Hence, sarcopenia is considered a 
significant public health issue, and the development of interventions to reduce its 
effects is an important research goal. 
 1.1.4 Aetiology 
The aetiology of sarcopenia is complex and multifactorial. It could be suggested that 
changes in lifestyle with increasing age, namely the reduction in physical activity, 
may be responsible for muscle loss. However, observations of performance in 
Masters weightlifting events indicate a progressive decline in performance with 
increasing age [17, 18], and data collected from Master weightlifters and untrained 
controls show a similar decline in both groups; in one study, the power results were 





results indicate a continuing effect of physical activity into older age, however the 
presence of a performance decline even in these highly active older adults indicate 
an underlying ageing process. 
An overview of the aetiology of sarcopenia is represented in Figure 1.1, which 
illustrates the decreases in muscle fibre number (hypoplasia) and fibre size (atrophy) 
as key processes [21]. It has been shown that the greatest difference between 
younger and older muscle is a loss of motor units as a result of neuropathic process 
[22, 23]. Electromyography data indicate a decrease in motor units of 40-60% by age 
70 [24, 25], which is not attenuated by exercise [26]; some abandoned muscle fibres 
are re-innervated, increasing the size of the remaining motor units, which may 
negatively affect fine motor control in older age [27]. The decrease in muscle fibre 
size which is also observed in older age shows greater atrophy of Type II fibres 
rather than Type I [28], and, combined with decreased numbers of motor unit and 
muscle fibres, causes a reduced muscle cross sectional area in older adults, While 
the causes of this decline are unclear, a number of factors have been implicated in 
these processes.  A mechanism of many ageing process is the presence of chronic 
low-grade inflammation; a comparison of inflammatory cytokine production in older 
and younger adults indicated higher levels of inflammation in the older group (mean 
age 79 years) [29], and these inflammatory cytokines have the potential to interfere 
with the signalling pathways which lead to anabolism and catabolism [30, 31]. Also 
implicated are hormonal changes, specifically factors such as serum testosterone 
and insulin-like growth factor 1 (IGF-1) which are thought to influence body 
composition in older men [32, 33], and nutritional factors, for example reduced 
energy intake in older adults presents a higher risk of malnutrition [34] While the 





this area have helped to identify various risk factors for sarcopenia. Some of these 
risk factors are modifiable, and are therefore important as potential targets for 








Figure 1.1: Schematic representation of the aetiology of sarcopenia (adapted from Narici and Maffulli 
[27]). 
 
1.2 Responsiveness of older muscle to anabolic stimuli 
 1.2.1 Definition 
Skeletal muscle proteins are in a constant state of flux, exhibiting a typical turnover 
rate of 1.2 %.day-1 [35]. Muscle protein balance is maintained by a combination of 
muscle protein synthesis (MPS) and muscle protein breakdown (MPB), which form a 
dynamic equilibrium. When MPB exceeds MPS, as occurs in the fasted or post-
absorptive state, there is an overall net loss of muscle proteins, and the muscle is 
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shifts in response to stimuli such as feeding and exercise, so that MPS exceeds 
MPB, resulting in an overall net gain known as an anabolic state. Changes in this 
balance are responsible for plasticity of the muscle, and are the main drivers of 
adaptation. 
1.2.2 Muscle protein synthetic response to resistance exercise and 
protein intake in younger adults 
Muscle proteins lost to catabolism in the post-absorptive state must be replaced, and 
this occurs in response to feeding, specifically in response to the ingestion of protein. 
Following a protein meal there is an increase in amino acid (AA) availability in the 
blood, which stimulates a transient increase in MPS until approximately two hours 
after feeding [36]. Another effect of a protein meal is an increase in the production of 
insulin; this does not influence the rate of MPS, as demonstrated by a study using 
insulin clamps in healthy young men, which reported no changes in MPS in response 
to fixed plasma insulin between 5 and 167 mU/l while constant AA availability was 
maintained [37]. However, this study also measured leg protein breakdown (LPB), 
and reported an increase in LPB in response to increasing insulin concentration with 
fixed AA availability up to plasma insulin concentration of 30 mU/l, but no effect of AA 
dose on MPB when insulin was clamped at 5 mU/l. Hence, protein consumption can 
cause both increased MPS and reduced MPB. This combination of increased 
synthesis and decreased breakdown produces the net muscle protein gain seen in 
the anabolic state, thereby replacing the proteins lost when fasted. This loss-gain 













Figure 1.2: Cycle of muscle protein synthesis and breakdown in fed and fasted states [38]. 
 
Another stimulus which may increase MPS is activity, in particular resistance 
exercise (RE). During the period following a bout of RE, MPS has been shown to 
increase up to threefold compared with baseline [39-41], an effect which may persist 
for up to 48 hours after exercise. However, Phillips et al. (1997) also measured 
breakdown in response to RE in the fasted state, and identified an increase of 31% 
above resting three hours after RE which remained elevated at 18% above resting 
after 24 hours, although with increases with MPS at these time points, net muscle 
protein balance was also raised above resting [41]. While these results reflect 
responsiveness to RE in the fasted state, the combined effects of protein feeding and 
RE are also important, and shall be discussed in Section 1.5.  
A key mechanism implicated in the anabolic response is the mammalian target of 
rapamycin (mTOR) pathway, specifically the mTORC1 complex. When this pathway 
is activated in response to an anabolic stimulus, a number of elements of 
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which promotes the translation of messenger RNA (mRNA). For example, initiation of 
mRNA translation requires the binding of three eukaryotic initiation factors, eIF4E, 
eIF4G, and eIF4A, which form the eukaryotic initiation factor complex. However, the 
formation of this complex in prevented by eIF4E binding protein 1 (4E-BP1), which 
binds to eIF4E, thereby preventing translation initiation. One of the mechanisms by 
which mTORC1 promotes translation when activated is to bring about the 
phosphorylation of 4E-BP1, which prevents it from binding to eIF4E and allows the 
complex of eIFs to form [42, 43]. Another role of mTORC1 is the regulation of 
elongation during translation; the activity of elongation factor 2 (eEF2) is inhibited 
when phosphorylated by elongation factor 2 kinase (eEF2k). P70 ribosomal protein 
S6 kinase 1 (P70S6K1) is activated as part of the mTOR signalling pathway, and can 
regulate translation elongation by phosphorylating eEF2k which prevents the 
inhibition of eEF2 [44]  
There is evidence in the literature from in vivo studies which does indicate 
involvement of the mTOR pathway in hypertrophy. Bodine et al. (2001) applied 
rapamycin to a rodent model; rapamycin is a known inhibitor of mTOR activity, and 
indeed downstream components of the pathway, such as p70S6K1 phosphorylation, 
were blocked. Crucially, hypertrophy, as measured by muscle weight and cross-
sectional area, did not occur with rapamycin [45]. In humans, Drummond et al. (2009) 
administered rapamycin to 15 healthy young men prior to exercise and compared 
MPS and downstream mTORC1 components with a non-rapamycin control group. 
Again, there were indications that the mTOR pathway had been inhibited as p70S6K 
phosphorylation increased and eEF2 phosphorylation decreased significantly in the 
control group only, and while MPS in the control group increased by 40% in the two 





particular study, components of the MAPK/ERK pathway were also measured and 
were unexpectedly blocked by the rapamycin treatment; it is plausible that the 
blocking of this pathway contributed to the inhibition of MPS, and therefore this study 
cannot definitively isolate the effects of the mTOR pathway. In a similar study, 
Dickinson et al. (2011) investigated the effects of 10g essential amino acids (EAA) 
with and without rapamycin in a crossover design in young adults, and again reported 
elevated MPS and mTOR signalling in the control group with was blocker in the 
rapamycin group, although this study did not measure components of other pathways 
potentially influence by rapamycin [47].  Furthermore, studies of muscle protein 
synthetic response to anabolic stimuli have also measured components of the mTOR 
pathway and found similar change profiles [36, 39, 40]. However, Atherton et al. 
(2010) reported similar changes in MPS and signalling profiles until 90 minutes after 
exercise, before a decrease in MPS despite the persistence of elevated signalling 
levels, indicating some disparity between signalling and response [48]. 
While much of the existing evidence indicating the importance of mTOR in humans 
involves signalling as an indicator of pathway activity and MPS as the hypertrophic, 
Phillips et al. (2013) utilised genetic transcript profiles to identify associations 
between the expression of mTOR sensitive genes and gains in lean mass [49]. Forty-
four participants aged 18-78 years completed 20 weeks of resistance exercise 
training (RET) and changes in lean mass were between -3% and 28%; conversely to 
much of the previous data, participants who exhibited the greatest gains exhibited 
suppressed expression of mTOR sensitive genes. It is suggested that baseline levels 
of rRNA may factor into this response, however the effects of the mTOR pathway and 






1.2.3 Anabolic resistance in older age 
Given that the balance between muscle protein synthesis and breakdown is 
responsible for the plasticity of skeletal muscle, it is logical to suggest that age-
related muscle decline may be a result of long-term changes to this balance. Firstly, if 
the basal catabolic state is considered, it was initially thought that basal MPS was 
lower and MPB higher in older age [50-53]. In a comparison of eight young (<35 
years) and eight older (>60 years), Welle et al. (1993) reported 44% lower rate of 
MPS in the older group [50]; Balagopal et al (1997) measured MPS in 24 individuals 
between the ages of 20 and 92 years, and results indicated a significant decline 
between young and middle age (52 years) [53]. However, these results are 
problematic, as the magnitude of the changes in muscle protein balance would cause 
the decline in muscle mass with age to exceed that which is actually observed [54]. 
More recently, Volpi et al. reported no significant difference in basal muscle protein 
turnover between younger and older men [55], and this result has been corroborated 
by baseline data in several studies measuring responses to anabolic stimuli [40, 56]. 
Protein losses in the fasted phase of the of the muscle protein loss-gain cycle do not 
appear to drive age-related muscle decline. Examination of the other side of this 
cycle, the anabolic fed state, has yielded different results. As first demonstrated by 
Dardevet et al. (2000) in muscle from young, adults, and old rats in vitro, the older 
muscle showed a diminished response to leucine [57]. In humans, Cuthbertson et al. 
(2005), measured MPS in a group of 20 young and 24 older men (mean ages 28 and 
70 years respectively) in response to EAA doses of 0, 5, 10, and 20g, and also 40g 
for the older group, reporting significantly lower responses in the older men [56], 
demonstrating a blunting of the anabolic response to protein feeding. Known has 





studies [58-61], however several studies by Symons et al., in which older and 
younger participants consumed equal servings of lean beef, found no such 
impairment of MPS [62, 63]. One potential explanation for this is the use of a whole 
food as the protein source rather than isolated EAA; this demonstrates the 
complexity of the subject of anabolic resistance, and its application to whole foods. 
 A similar pattern of anabolic resistance has been reported in response to resistance 
exercise. In a study by Kumar et al. (2009), two groups of 25 young and older men 
(mean age 24 and 70 years) performed resistance exercise at one of five intensities 
between 20% and 90% of their 1-repetition maximum (1-RM) for leg extensions and 
flexions, with the numbers of sets and repetitions set to equalise the volume of work 
across each intensity, and MPS was measured at 1, 2 and 4 hours after exercise 
[40]. Results indicated a sigmoidal dose-response relationship between exercise 
intensity and MPS, with the greatest increase between 40% and 60% 1-RM, and 
crucially MPS was significantly lower in the older group. Basal MPS was identical in 
the younger and older groups, the 1-2 hour timepoint represented both the peak MPS 
for both groups and the only point where the groups were statistically significantly 
different, and the return to basal values by the 2-4 hour time indicates that this 
measurement period was sufficient to detect the MPS response to the exercise. 
These results indicate that responsiveness to resistance exercise is also subject to 
anabolic resistance. This phenomenon of anabolic resistance has been implicated as 
a potential cause of sarcopenia. It is suggested that the optimisation of anabolic 
responsiveness to ‘rescue’ this effect may be achieved using modifiable lifestyle 
factors, thereby presenting an effective target for intervention. 
References to anabolic resistance generally focus on MPS, and as described in the 





response is the difficulty of its measurement. There is some evidence of anabolic 
blunting of MPB in older adults, Wilkes et al. (2009) measured MBP in younger and 
older adults (mean ages 24.5 and 65.0 years), basally and in response to a plasma 
insulin concentration of 15 µIU/ml [64]. While there was no significant difference 
between the groups in terms of basal MPB, in response to insulin, the younger group 
exhibited suppression of MPB of 47% from baseline, but only 12% in the older group 
which was not statistically significant. Hence, anabolic resistance appears to affect 
both elements of muscle protein balance, however it is generally considered the MPS 
is the predominant driver of changes in muscle mass [65-69], and in terms of 
anabolic resistance the main focus of this thesis is therefore MPS. 
 1.2.4 MPS measurement 
A vital component of understanding the influence of external factors on MPS is the 
ability to measure MPS, which is achieved using stable isotope technology. Isotopes 
are elements which contain the same number of protons and electrons, but differ in 
the number of neutrons, so share chemical properties but have a different atomic 
mass. The “heavier” isotopes are usually rarer, for example 12C is the most abundant 
carbon isotope on Earth, while 13C is a stable isotope which only account for 1.1% of 
the Earth’s carbon [70]. Stable isotopes are safe for use in humans, as opposed to 
radioactive isotopes, such as 14C, which are subject to radioactive disintegration. 
The basis of MPS measurement is to use these stable isotopes as a tracer, which is 
introduced to the subject within a precursor, and incorporated into the muscle as new 
muscle proteins are synthesised. Enrichment of the samples can be measured using 
isotope ratio mass spectrometry (IRMS), which distinguishes different isotopes based 





labelling ratio provides a basis for the calculation of the fractional synthesis rate 
(FSR) of muscle proteins. 
The most well-established method of measuring MPS involves the provision of a 
combination of labelled and unlabelled amino acids as the tracer and tracee 
respectively. Amino acids are provided as either a primed constant infusion or as a 
flooding dose, and are incorporated into the endogenous supply where they are 
available for the synthesis of new muscle proteins [71]. One of the more commonly 
used tracers is leucine labelled with 13C ([1, 2-13C2]leucine), as used in several of the 
studies described previously in this section; Kumar et al. (2009) supplied a primed 
continuous tracer infusion, obtained blood samples to measure precursor enrichment 
and muscle biopsies for product enrichment [40]. In this case, samples were taken 
before and after a bout of resistance exercise, to provide data for baseline and 
exercise response; an outline of the experimental methodology is shown in Figure 
1.3. Another commonly used amino acid is phenylalanine, which may be labelled 
using 13C or 2H [72, 73].However, a significant limitation of this technique is the need 
for continued invasive procedures, in particular cannulation for tracer infusion and 
repeated blood samples. Hence, studies are restricted to controlled laboratory 
conditions. Furthermore, this method can only be used for relatively short studies 
















Figure 1.3: Example of amino acid tracer infusion protocol for measurement of MPS [40]; primed 
infusion of labelled amino acids throughout the protocol, with regular blood samples to measure 
precursor labelling, and muscle biopsies to measure product labelling and the start of the protocol, and 
prior to and following a stimulus (i.e. resistance exercise). 
 
An alternative technique has been developed which overcomes these limitations. A 
stable isotope of hydrogen (H) is deuterium (D or 2H), which has a natural abundance 
of 0.02% [70]. Deuterium oxide (D2O), also known as heavy water, was first proposed 
for use in measurement of protein synthesis in 1941 [74], and the technique has 
been developed in recent years. The tracer, D2O, can be ingested orally, and is 
rapidly incorporated into the body water pool. Via the process of transamination, 
amino acids such as alanine are labelled, as D atoms equilibrate with H atoms in free 
amino acids [75, 76]. Significantly, this labelling can occur intracellularly, unlike 
amino acids tracer methods in which the labelled amino acids must be transported 
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When using stable isotope techniques, MPS is presented as a fractional synthesis 
rate (FSR), which refers to the rate of precursor incorporation of the project per unit 
of product. For  D2O measurement of MPS, FSR can be calculated using the 
following equation [71]: 
FSR = [(MPEAla)] x (n x MPEBW x t) x 100 
MPEAla and MPEBW (mole percent excess) refer to D labelling of protein-bound 
alanine and of body water respectively. The former is measured in muscle biopsy 
samples, and the latter from saliva samples. n is the mean number of D molecules 
incorporated per alanine (3.7 in mammals) and t is the time between biopsies. 
Given that the tracer can be given orally rather than as an infusion, and precursor 
incorporation measured from saliva rather than blood samples, this method is 
significantly less invasive than previous protocols and is therefore more suitable for 
measurement of MPS in free-living participants. The technique also allows the 
measurement of MPS over a longer duration not feasible with infusion protocol 
methods, although this may also be considered a limitation in terms of loss of 
resolution and sensitivity; measurement over a time course of days rather than hours 
eliminates the ability to measure the response to specific stimuli. 
There are a number of examples in the literature of the implementation of this 
technique in humans [77-83]. For example, Wilkinson et al. (2014) measured MPS in 
young men completing an 8-day unilateral RET programme [84]. Participants 
consumed a 150ml D2O bolus on Day 0. Muscle biopsies were taken on Days 0, 2, 4, 
and 8, and saliva was sampled daily; results indicated significantly greater MPS in 
the exercised legs across the 8-day protocol (p<.05). A longer study was undertaken 





which time they consumed a 150ml D2O bolus on Day 0 with weekly 50ml top-up 
doses, and provided regular saliva samples [81]. Muscle biopsies were taken on Day 
0, and after 3 and 6 weeks. MPS in the trained leg was 1.6 %.day-1 between Weeks 
0-3, which was significantly greater than the untrained leg (p<.05), however this fell to 
1.29 %.day-1 in Weeks 3-6 which was the same as the untrained leg. This pattern 
was also reflected in the mTOR signalling response.  Hence, D2O has been shown to 
be effective in the measurement of MPS over an intermediate time scale. 
Data obtained using these techniques will be referred to throughout the thesis. 
However, it should be noted that while muscle protein breakdown is also an 
important component of the anabolic response, it is less frequently used as an 
outcome measure, as many technical difficulties are associated with its 
measurement. For example, indirect methods such as the measurement of urinary 3-
methlyhistidine (3-MH), a product of protein breakdown, has the benefit of being non-
invasive, however requires the assumption that skeletal muscle is the sole source of 
excreted 3-MH, which doesn’t consider smooth and cardiac muscle or metabolism of 
ingested meat [85]. Measurements involving stable isotope tracers are highly 
invasive, requiring catheterisation to obtain venous and arterial blood samples as 
well muscle intracellular samples, and require an assumption of a physiological 
steady state, which creates difficulties in measuring changes in response to stimuli 
[86]. Also, the separation of rates of MPS into different subfractions (myofibrillar, 
sarcoplasmic, etc.) is a useful tool which is more problematic when measuring MPB. 
Recent advances include the development of a method for MPB measurement using 
D2O, firstly in rodents before being applied to humans, in which the rate of 
disappearance of labelled alanine following deuterium incorporation can be used to 





allows greater specificity, in that the breakdown of a particular protein can be 
selected, and is less invasive so can obtain measurements from free-living 
participants. However, as with measurement of MPS using D2O, the resolution of the 
measurement is such that acute responses to stimuli cannot be measured, and the 
MPS and MPB techniques cannot be employed simultaneously to allow calculation of 
muscle protein balance [86]. Hence, advancements in the measurement of MPB 
continue to develop, but they have not matched those of MPS measurement [35].  
1.3 Resistance exercise training 
 1.3.1 Definition 
Section 1.2.2 identifies RE as one of the factors which may stimulate an increase in 
MPS, and may therefore have a role in alleviating the effects of sarcopenia. 
However, thus far in this chapter only the acute effects have been described, i.e. the 
response in the hours immediately after a bout of exercise. To assess its potential as 
an intervention which may influence chronic muscle loss or gain, the long-term 
effects of repeated bouts of RE, or resistance exercise training (RET), must be 
considered. 
The relationship between acute anabolic responsiveness and chronic adaption to 
RET is still unclear; it is suggested that adaptation may occur through the 
accumulation of mRNA and the encoded protein as a result of repeated increases in 
anabolic signalling in response to RE. Associations have been found in rodents and 
humans between activity of elements of the anabolic signalling pathway following an 
initial bout of RE, such as p70S6K1 phosphorylation [88, 89] and IGF-1 mRNA 
expression [90, 91], and subsequent muscle hypertrophy after a period of training. 





and MPS, therefore these measures of signalling alone are not sufficient to deduce a 
connection between acute increases in MPS and longer-term hypertrophy. Mitchell et 
al. (2014) measured MPS at rest and for 1-3 and 3-6 hours after the first session of a 
16 week RET programme; while there was evidence of hypertrophy in that 
quadriceps volume increased by 7.9%, this did not correlate with acute MPS rates 
following the first exercise session [92](Ref Mitchell). However, these studies only 
consider anabolic signalling at the start of a training programme, allowing no 
distinction to be made between initial and subsequent responses to RET, which may 
be particularly pertinent if participants are previously untrained. Damas et al. (2016) 
addressed this limitation by considering different phases of a 10-week training 
programme, by taking measurements at baseline (T1) and weeks 3 (T2) and 10 (T3) 
[93]. Muscle biopsies were collected 24 hours and immediately before exercise at 
these timepoints, as well as 24 and 48 hours after, and D2O techniques were used to 
measured MPS, while muscle damage was also measured from 0 and 48 hour 
samples, and fibre cross sectional area (fCSA) was measured as an indicator of 
hypertrophy. Both muscle damage and post-exercise MPS were highest at T1 but not 
correlated with fCSA, while MPS was the same at T2 and T3, and both were 
correlated with hypertrophy. These results indicate different influence of acute MPS 
on hypertrophy at different points in the training programme, and it is suggested that 
this may be a result of greater muscle damage after the initial exercise session. While 
these findings address the issue of immediate and longer-term MPS responses to 
RET, it could be argued that some elements of the response were lost by the use of 
D2O rather than a tracer infusion protocol, as the immediate changes in MPS in the 





 1.3.2 RET as an intervention improve muscle strength and function in 
older adults 
It is widely accepted that RET can lead to improvements in skeletal muscle strength, 
size, and body composition [94]. As demonstrated by Kumar et al. (2009), resistance 
exercise is capable of eliciting an increase in MPS from baseline levels of up to 75% 
in older adults, and, as may be expected, this is reflected in the chronic 
responsiveness to RET [40]. A systematic review by Liu and Latham (2009), included 
121 trials (n = 6700 participants) assessing the effects of RET in adults with a 
minimum mean age of 60 years [95]. Significant improvements were reported in 
measures of muscle strength and functional ability in response to RET, with 
standardised mean differences of 0.84 for lower limb strength (73 trials, n = 3059, 
“large” effect), and 0.94 chair rise time (11  trials, n = 384, “moderate to large” effect), 
and a mean difference of 0.08 m/s for gait speed (24 trial, n = 1179, “modest” effect). 
This result also holds true in the older old; Stewart et al., 2013, identified four studies 
which implemented physical training in adults aged ≥75 years, reporting 
improvements in muscle mass of 1.5-15.6% in three trials (with a decrease of 3% in 
the fourth), a mean difference of 2.31cm2 for thigh muscle cross-sectional area, and a 
standardised mean difference of 1.04 for muscle strength from a total of n = 143 
participants [96]. This result indicates a greater magnitude of improvement than in 
the previous systematic review by Liu and Latham, however with only thee trials 
included in the meta-analysis, results may have been influenced by variability in the 
trial durations, which ranged from 10 weeks to a year.  An additional systematic 
review indicates that this can also be applied to frail older adults, with significant 
improvements reported in muscle mass, strength and power, as well as physical 





In fact, despite 30 years of research into effective interventions to protect against 
sarcopenia, RET remains the only intervention which has shown any real impact in 
terms of improving muscle-related outcomes in older adults. 
 1.3.3 Blunted chronic responsiveness to RET in older adults 
Although the effects of RET on older muscle are well documented, the results are not 
equivalent to those observed in younger adults. Kumar et al. (2009) demonstrated 
the phenomenon of anabolic resistance in terms of the acute response to RE, and it 
has been shown that this translates into blunting of the chronic responsiveness to 
RET in older adults compared with younger adults [40]. For example, measurements 
of muscle mass and strength in older and younger women (median ages 26 and 80 
years) in response to a 12-week RET programme indicated significantly lower gains 
in the older group [98]. Analysis of gene expression from muscle biopsies also 
indicated lesser ability to upregulate anabolic mTOR signalling in response to 
resistance exercise in the older group. Similarly, Brook et al. (2016) reported blunted 
hypertrophic responses following six weeks of RET in older adults, and an increase 
in leg-extension strength of 25% in older men which was significantly lower than the 
35% reported in younger adults (p < .01) [82]. MPS was also measured using D2O 
throughout the study, and was found to increase in the younger participants only, 
between Weeks 0-3. 
Hence, RET can be used as an effective intervention to reduce the effects of 
sarcopenia, but the improvements do not match those which can be achieved by 
younger adults. An important research goal is therefore the optimisation of 
responsiveness to RET to lessen this deficit. 





 1.4.1 Acute response 
A number of studies have investigated the time course of the anabolic response to 
protein. During a 6-hour infusion of amino acids in younger adults, Bohe et al. (2001) 
observed a 30-minute latent period, followed by a rapid increase in MPS which 
peaked at approximately 2.8 times the basal rate after 2 hours, followed by a rapid 
decline to basal values [99]. This final decline was in spite of continued AA 
availability. A similar time course has been reported in the anabolic response to a 
bolus of whey protein, in a study which also measured phosphorylation of p70S6K1 
and 4EBP1 as components of the mTOR signalling system [36]. Again, the decline in 
MPS back to the basal value was in spite of plasma EAA availability, as well as 
continued signalling via the mTOR pathway. This limit of EAA utilisation for MPS has 
been termed the “muscle full” effect, meaning that the anabolic effect of EAA is 
transient, and in the presence of continued availability muscle will not continue with 
elevated MPS indefinitely. 
The relationship between the size of protein meal and the magnitude of anabolic 
response is also important. Studies such as that of Cuthbertson et al., (2005) which 
measured the acute MPS response to a range of EAA doses between 0 and 40g, 
showed that there is a dose-response relationship between intake and response 
(Figure 1.4) [56]. This dose-response relationship was also present in older adults, 
however the authors note a depressed dose response curve which is shifted to the 
right; this indicates a blunting in the magnitude of the response, and higher doses 
needed to produce similar levels MPS, all of which is indicative of anabolic blunting 
[56]. It has also been noted that this dose-response relationship continues only to a 
threshold protein dose, beyond which additional protein does not elicit any further 





muscle [56, 61]. Yang et al. (2012) identified the threshold beyond which there was 
no additional response to be 20g at rest in older adults, based on the responses of 
older men to 10, 20, and 40g whey protein; this cut-off was based on statistically 
significant differences in MPS between 0g and 20g but not between 20g and 40g 
[60]. However, caution should be used when using this threshold to generalise, as it 
refers specifically to the responses of older men, while there are indications of sexual 
dimorphism in muscle protein turnover in older age [101]; also, as discussed 
subsequently in Section 1.4.3, responsiveness may be influenced by the source of 
protein, which may also affect this threshold. Symons et al. (2009) estimate a 
threshold of 30g based in the responses of young and older men and women to 
portions of lean beef containing 30g and 90g protein (equivalent to 10g and 30g 
EAA). MPS did not differ between doses, however with such a large difference 
between these doses, further research with a range of dose closer to 30g would be 
needed to identify a more specific threshold [60, 63]. An alternative analysis pooled 
data from a number of studies measuring MPS in response to various protein doses 
to better define the dose-response relationship. Breakpoint analysis was used to 
identify the plateau threshold, but with protein intake expressed relative to body 
weight [100]. Again, the threshold was found to be higher in older adults; threshold 
doses were reported as 0.24 and 0.40 g.kg-1 for younger and older men respectively. 
Hence, the anabolic response to protein is limited both in duration, i.e., MPS returns 
to baseline after two hours in spite of continued stimulus, and in magnitude, as 













Figure 1.4: The relationship between protein dose and MPS is response is both 
dose-dependent and saturable, for example Cuthbertson et al. compared responses 
to a range of EAA doses in older and men, and found the curve to be blunted in older 
men. [56]. 
 1.4.2 Factors affecting response 
Protein is comprised of amino acids (AA), which can be categorised as either 
essential (EAA) or non-essential (NEAA), and it is thought that it is EAA which are 
primarily responsible for the anabolic response to protein feeding [55, 102-105]. 
Tipton et al. reported increased nitrogen uptake in response to 13.4g EAA, indicating 
that EAA alone are sufficient to stimulate MPS and NEAA are not necessary [103], 
although not that they were unable to; Smith et al. provided flooding doses of 
individual AA, and reported indications of MPS with EAA phenylalanine and threonine 
but not with NEAA glycine or serine, although the EAA arginine also failed to produce 
a response [102], but again this does not show that a greater response could not be 
reached with combined EAA and NEAA. In older adults, Volpi et al. (2003) compared 
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additional 22g NEAA [105]. The addition of the NEAA elicited no additional response, 
which would appear to indicate that they do not have any effect on the anabolic 
response, however the dose size of the EAA given to both groups should be 
considered; previously, doses 20g of EAA [56] or protein [106] have been found to be 
the threshold doses for maximal response, thus with a dose of 18g EAA given to both 
groups there was little potential for improvement. Hence, it is still generally 
considered that EAAs are the primary drivers of the anabolic response, however the 
evidence less than clear cut. 
As well as providing substrate for MPS, AA act as a trigger to initiate the MPS 
process, and leucine specifically is thought to be the most potent initiator. A number 
of animal studies have shown the ability of leucine to signal the mTOR pathway 
which is crucial to MPS [107-109]. Atherton et al. (2010) stimulated myocyte cells 
with each EAA individually and observed the effects of phosphorylation of the mTOR 
pathway; only leucine increased phosphorylation of mTOR and 4EBP1, and the 
phosphorylation of p70S6K1 and  ribosomal protein S6 (RPS6) increased 5.9-fold 
and 3.8-fold respectively with leucine, both of which were significantly greater than 
with other EAA [48]. Recently, MPS was measured in young and older men following 
a bout of RE and a 10g protein drink supplemented with 4.2g of either leucine or 
alanine. Greater MPS and p70S6K1 phosphorylation were reported with the leucine 
drink in both age groups [110]. However, another recent study in post-menopausal 
women has compared anabolic signalling and MPS in response to either a whey 
protein drink containing 0.45 g.kg-1 FFM of protein including 0.0513 g.kg-1  of leucine, 
the same amount of leucine only, or a control drink during a hyperinsulinaemic-
euglycaemic clamp to eliminate the different effects of the drink on insulin production 





drinks stimulated anabolic signalling, but only the protein drink decreased eIF2 
phosphorylation by 35% and stimulated a significant increase in MPS of 100%. 
Hence, again while there does appear to be of particular role of leucine in the 
anabolic response, the importance of other AA should not be discounted. 
 1.4.3 Effect of protein quality on response 
Protein quality may be described as the ability of an ingested protein to stimulate 
MPS [112], and is dependent upon the digestibility of the protein, as well as the 
amino acid profile as indicated in the previous section. Proteins can be referred to as 
‘fast’ or ‘slow’ depending on how quickly they are digested, and a number of studies 
have compared the metabolic response of proteins with different digestibility. For 
example, Dangin et al. (2001) analysed leucine kinetics following one of four protein 
doses; doses were identical in terms of AA composition but differed in rate of 
digestion [113]. The ‘fast’ doses (whey, free AA mimicking casein composition) 
produced more rapid aminoacidemia and leucine flux than the ‘slow’ doses (casein, 
whey divided into 13 smaller doses to imitate a slower digestion), while leucine 
balance over the 7-hour observation period was higher with the ‘slow’ doses. 
Similarly, Koopman et al. (2009) compared the responses in older men to casein and 
hydrolysed casein, which is more rapidly digested; plasma AA concentrations were 
significantly greater following the hydrolysed casein (p < .01) [114]. 
The effect of the amino acid profile has been demonstrated by a study comparing 
responsiveness to ingestion of whey and soy protein in older men, both of which are 
rapidly digested proteins, but whey has a higher leucine content [106]. Myofibrillar 
MPS over the four hours after ingestion was significantly greater with whey protein 





This has implications for dietary protein, as the quality of protein varies depending on 
its source. There is evidence of higher quality protein content in animal proteins 
compared with plant-based proteins [106, 115, 116]. Hence, a diet with contains a 
greater proportion of protein derived from animals may be considered beneficial. 
 1.4.4 Increased requirements in older adults? 
The question of dietary protein requirements of older adults is a controversial one, 
which shall be referred to in several chapters of the thesis. Just as resistance 
exercise stimulates an acute anabolic response which translates to responsiveness 
to RET in chronic muscle related outcomes, it has been suggested that increasing 
protein intake in older adults may increase anabolism and therefore have similar 
effects. Hence, increased protein intake could be used to help overcome the issues 
of sarcopenia. 
Currently, the recommended daily allowance (RDA) for protein for older adults does 
not reflect this premise; the RDA of 0.8-1.2 g.kg-1.day-1 is the same as that of 
younger adults [117]. However, this is based on nitrogen balance studies [118], and it 
due to the limitations of this method, such as the difficulties in monitoring all possible 
routes of nitrogen intake and output, the inability to identify redistribution of nitrogen 
across difference tissues, and the problems with detecting turnover on muscle over 
shorter durations, it is suggested that this may produce inaccuracies in determining 
optimal intake in older adults [119]. There is a growing evidence base which indicates 
the benefits of higher protein intake in older adults, although much of this evidence 
come from the identification of associations between factors, so is not able to 
demonstrate a causal link. For example, when protein intake data from the Health 





association with loss of lean mass over the three-year follow-up, although. [120]. 
Less mass was lost with higher protein, with a difference of 40% between the highest 
and lowest quintiles. Furthermore, Genaro et al. (2015) evaluated dietary protein 
intake and body composition in 35 sarcopenic and 165 non-sarcopenic women aged 
over 65 years, and reported dietary protein to be a predictor of muscle mass, with 
significantly higher muscle mass in those consuming >1.2 g.kg-1.day-1 [121]. 
Consequently, an evidence-based recommendation has been produced which 
suggests that an increase in the lower end of the recommended intake range to 1.0-
1.2 g.kg-1.day-1, would be advisable for older adults [119]. However this 
recommendation remains controversial, as there is also evidence which does not 
indicate a need for higher protein intake in older adults. The recommendation 
suggests that older adults’ requirements are higher than those of younger adults, 
however comparisons of nitrogen balance in young (age 21-46 years) and healthy 
older participants (63-81 years) in response to three 18-day trials, during which they 
consumed 0.50, 0.75, and 1.00 g.kg-1.day-1 protein, indicate the same requirements 
for both groups [122]. Participants (age 50-80 years) in a study by Iglay et al. (2009) 
consumed diets containing either 0.9 or 1.2 g.kg-1.day-1 for 12 week alongside an 
RET programme, and there was no effect of diet on body composition, again 
indicating no benefit of increased protein intake [123]. A recent meta-analysis 
investigated the effects of protein or AA supplementation in older adults, and from 
eight trials (n = 557) the analysis reported no significant effect of supplementation on 
LBM  or strength, despite the inclusion of supplemented doses up to 30g whole 





The question of actual dietary protein intake in older adults, relative to 
recommendations, will be addressed in Chapter 4 within a sample of community-
dwelling adults aged 70 years and older. 
Regarding the question of protein supplementation as an intervention to protect 
against the effects of sarcopenia, this has been addressed in several systematic 
reviews. Xu et al. (2015) included 9 randomised controlled trials of participants aged 
≥65 years (n = 267 participants), which compared efficacy of protein/EAA 
supplementation with that of a placebo, ranging from 9 days to 6 months in duration 
[125]. Results indicated no effect of supplementation on measures of lean body mass 
and muscle strength. The effects of protein supplements have also been considered 
in older adults who are at risk of malnutrition; a Cochrane review of 62 studies (n = 
10,187 participants) concluded that protein intake did not influence measures of 
functional status, which included muscle functioning (i.e., strength and power), 
mobility, and activities of daily living [126]. 
 1.4.5 Effect of protein distribution on responsiveness to protein intake 
While there is continued debate over the importance of total protein intake in 
preventing sarcopenia, there may also be a role for the pattern of protein intake, i.e., 
protein distribution. Given the transient and saturable nature the of anabolic response 
to protein described in previous sections, the way in which protein meals are divided 
into doses may influence the MPS response they elicit, and therefore impact upon 
other aspects of musculoskeletal health. 
Evidence for significant effects of protein distribution on MPS in younger adults is 
mixed. A study in which participants were provided with 1.0 g.kg-1.day-1 egg protein 





over 24 hours, or to 10 smaller hourly protein meals over the same period, 
demonstrated greater protein retention with the former [127, 128]. MPS can be 
similarly influenced; this was demonstrated during a 12-hour recovery period from a 
bout of resistance exercise, in which young men consumed 80g protein as either 
8x10g doses every 1.5 hours, 4x20g every 3 hours, or 2x40g separated by 6 hours 
[129]. There were significant differences in MPS over the recovery period, with the 
intermediate distribution, consisting of 4 x 20g doses, eliciting the greatest response. 
Over a slightly longer period, Mamerow et al. (2014) used a 7-day crossover design 
to compare the effects of 3 daily protein meals of ~30g each (even), with 3 meals 
containing 10g, 15g and 65g of protein (skew), using a 24-hour stable isotope tracer 
infusion protocol on Day 7 of each to measure MPS [130]. They reported 25% 
greater 24-hour MPS with the even distribution. On the other hand, a 14-day trial of 
similar distributions in young women identified no difference in protein retention [131]. 
Mitchell et al. (2015) also reported no effect of protein distribution, when measuring 
the MPS response in participants fed 15g EAA as either a single bolus or 4 fractions 
[132]. However, in this case the doses were separated by only 45 minutes, and given 
the time course of the anabolic response shows a return to baseline after 
approximately 120 minutes [36, 99], these doses would have been too closely 
spaced to elicit distinct responses.  
With respect to older adults, the evidence base is even more limited, but the results 
of several cross-sectional studies indicate that the distribution of dietary protein 
across the day may affect chronic outcomes. In a dietary survey of volunteers aged 
≥75 years, protein intake was determined, along with frailty status assessed 
according to Fried’s frailty phenotype, which consists of five criteria including low grip 





intake, but with unevenness of intake, i.e., the amount of protein in each meal was 
more similar in non-frail participants, akin to the ‘even’ distribution used in studies 
described above [130, 131]. Loenneke et al. (2016) also found an association 
between per meal protein intake, leg lean mass, and knee-extensor strength in older 
adults; both outcomes were greater in participants who more frequently consumed 
meals containing more than 30g protein (i.e., the proposed threshold for maximal 
MPS) [134]. 
Experimental data relating to the chronic effects of protein distribution in older adults 
is relatively scarce. Evaluation of the existing evidence in this area is the subject of a 
systematic review in Chapter 3, and an intervention study assessing the effects of 
protein distribution in older adults is reported in Chapter 5. 
1.5 Effect of combining RET and protein supplementation on anabolic 
responsiveness  
 1.5.1 Acute 
As well as the individual influence of resistance exercise and protein 
supplementation, a combination of the two can have additive effects on muscle 
protein balance, by the increased stimulation of MPS, and by the suppression MPB 
with is otherwise elevated following RE [65]. RE sensitises muscle to the effects of 
protein feeding, enhancing subsequent MPS elevation. Moore et al. (2009) measured 
MPS from bilateral muscle biopsies in young men in the fasted state, and then 1, 3 
and 5 hours after a bout of unilateral RE and ingestion of 25g whey protein [135]. The 
non-exercised leg showed elevated synthesis of 163% above fasted levels at only 
the 3-hour timepoint, whereas elevated synthesis was maintained at all time points in 





increased both the duration and magnitude of the MPS response to feeding. This 
effect has been reported elsewhere [66, 136, 137], and Moore et al. (2011) also 
reported increased mTOR signalling reflective of the differences in MPS [138]. 
Furthermore, Burd et al. (2011) determined that sensitisation of the muscle persists 
for 24 hours after RE [72]. 
This acute sensitising effect has also been reported in older adults [106, 136, 137]. In 
fact, Pennings et al. (2011) measured the effect in both older and younger 
participants (mean ages 74 and 21 years) and reported no age effect on the efficacy 
of exercise-induced increases in MPS [137]. Drummond et al. (2008) also compared 
older and younger adults (mean ages 70 and 30 years), and found similar MPS 
increases in both age groups, although the response was delayed in the older group 
[136]. A recent systematic review of age-related anabolic resistance included 
comparisons of young and old MPS in response to exercise, nutrition, and a 
combination of both, and concluded that the acute MPS response to both was 
comparable between the age groups [139]. 
 1.5.2 Chronic effects of RET and protein supplementation in younger 
adults 
Given the additive effects of protein and resistance exercise in an acute setting, it 
may be considered that an RET intervention which also integrates protein 
supplementation may yield greater results. The evidence suggests this to be the case 
in younger adults. A systematic review of studies involving at least six weeks of RET 
combined with a protein supplement in at least one group concluded that 
supplementation augmented the effects of RET in terms of fat free mass (FFM) and 





conclusion. Morton et al. (2017) reviewed 49 studies (n = 1,863 participants) 
comparing the effects of RET with and without protein supplementation [141]. 
Average augmentation of the effects of RET of 9%, 27%, 38% and 14% were 
reported for 1-RM, FFM, fibre cross sectional area (CSA) and mid-femur CSA 
respectively. The analysis also included meta-regression to allow for continuous 
covariates, which included total daily protein intake, and a breakpoint analysis similar 
to that used by Moore et al. [100] to determine the threshold protein dose for maximal 
MPS; these results were consistent with a protein intake threshold for changes in 
FFM, showing no increased gains beyond a total intake of 1.6 g.kg-1.day-1.  
 1.5.3 Older adults 
The responsiveness of older muscle differs from younger muscle in a number of 
ways, including blunted acute anabolic responsiveness, blunting of chronic 
adaptation, and a higher threshold for maximal MPS. Hence, despite comparable 
responses to combined exercise and protein when the intensity and dose are 
sufficient [139], it is plausible that the effects of supplementing RET with additional 
protein may also differ in older adults. Indeed, the meta-regression analysis in the 
systematic review of Morton et al. (2017) included age as a covariate, and indicated 
a reduction in the influence of supplementation with increasing age [141]. 
While the evidence base is more limited for older adults, the combination of RET and 
protein has been the subject of several previous systematic reviews [140, 142]. 
However, the definition of “elderly” used in these reviews may be questioned, and 






1.6 Aims and objectives 
Using existing literature, as well as data from current dietary habits of older adults, to 
the overall aim of this thesis is to identify areas for improved efficacy of protein 
delivery on outcomes relating to muscle health. 
The objectives are:  
1. Systematically review the literature to determine the influence of 
supplementing with protein in older adults (mean age ≥70 years) on the 
effectiveness of RET 
2. Systematically review to evaluate the existing evidence relating to the timing 
and/or distribution of protein intake in older adults (mean age ≥65 years) 
3. Assessment of the current dietary habits of the intervention target 
population, relative to recommendations for protein intake 
4. Conduct an intervention study to determine the influence of manipulating 
protein distribution on the responsiveness of older muscle to resistance 
exercise training, in terms of (a) muscle protein synthesis, measured using 










2. SYSTEMATIC REVIEW: COMBINING RESISTANCE EXERCISE TRAINING 
WITH PROTEIN SUPPLEMENTATION IN OLDER ADULTS 
Objective: Systematically review the literature to determine whether regular dietary 
supplementation with protein/EAA during a RET regimen augments the effects of 
RET on skeletal muscle in older adults. 
Methods: A literature search was conducted in August 2015 using MEDLINE, 
EMBASE, SPORTDiscus and CINAHL Plus to identify all controlled trials using a 
RET regimen with and without protein/EAA supplementation. Primary outcome was 
muscle strength, and secondary outcomes were muscle size, functional ability and 
body composition. 
Results: Fifteen studies fulfilled the eligibility criteria, including 917 participants with 
a mean age of 77.4 years. Studies involving both healthy participants and those 
described as frail or sarcopenic were included. Overall, results indicated that protein 
supplementation did not significantly augment the effects of RET on any of the 
specified outcomes. Exceptions included some measures of muscle strength (three 
studies) and body composition (two studies). Meta-analyses were conducted but 
were limited due to methodological differences between studies, and results were 
inconclusive.  
Conclusions: Systematic review and meta-analysis of controlled trials reveal that 
protein/EAA supplementation does not significantly augment the effects of 









 2.1.1 Rationale 
Resistance exercise and protein ingestion have received a great deal of attention as 
potential components of interventions to protect against sarcopenia, due to their 
ability to acutely stimulate (MPS). However, as noted in the previous chapter, only 
resistance exercise training (RET) has demonstrated significant improvements in 
muscle related outcomes in older adults, and its efficacy is still less than that of 
younger adults. It has been proposed that a combination of RET and protein 
supplementation may elicit greater effects than either intervention alone. 
As discussed in Chapter 1, resistance exercise and protein ingestion have acute 
additive effects on the rate of MPS, which has been observed in both younger and 
older adults. In younger adults this appears to translate into chronic improvements in 
muscle related outcomes; a systematic review has demonstrated greater 
improvements in FFM (mean difference 0.69kg) and muscle strength (1-RM leg 
press, mean difference 13.5kg) with RET and protein supplementation compared 
with RET alone [140]. However, given that older muscle exhibits a blunted response 
to both resistance exercise and protein ingestion as individual stimuli, the 
effectiveness of a combined intervention in older adults requires separate 
consideration. 
This issue has been addressed in two previous systematic reviews, which have 
reported some additive effects of RET and protein/ EAA supplementation, in terms of 
fat free mass (FFM) [140, 142] and muscle strength [140]. However, there are issues 
with these reviews. Both used a relatively young minimum age limit to define ‘older’ 





subgroup analysis of ‘older’ adults, and the oldest participant included was 72 years 
[140]. In the other, the lower age limit was an average of 60 years and included 
studies in which some participants were as young as 50 years [142]. These age 
categories are not necessarily representative of older adults; longitudinal evidence 
shows that muscle strength and power continue to decline into advanced older age 
[143], and a dramatic increase in the prevalence of sarcopenia has been observed in 
the eighth decade of life [3]. Hence, the performance of the muscle of a 50-year-old 
differs compared to that of someone aged 70 years or even older, meaning that the 
responsiveness to anabolic stimuli is also likely to differ. The inclusion of such 
relatively younger participants may therefore mask any difference in the effects of the 
intervention on truly older adults; an older age limit would be more appropriate. 
Furthermore, the most important outcomes for older adults in terms of a practical 
impact of an intervention are those related to functional ability. Such outcomes are 
highly relevant to quality of life and the maintenance of an independent lifestyle, 
which are key priorities when setting lifestyle recommendations, but were not 
addressed within previous systematic reviews. 
 2.1.2 Aims 
The aim of this systematic review was to determine whether protein or EAA 
supplementation can augment the effects of RET in older adults, i.e., studies with a 
mean age of 70 years or older. These effects include changes from baseline in 
muscle strength as the primary outcome, and secondary outcomes of muscle size, 
body composition and indicators of functional ability, where functional ability was 
defined as the ability to perform everyday tasks and activities important for the 







The systematic review was conducted in accordance with the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) report [144]. Although 
this protocol has not been previously published, all procedures were determined in 
advance.  
2.2.1 Information sources and search 
An electronic search of online databases was conducted in August 2015, using 
selected key words, ‘free text’ terms, indexed terms, and Boolean operators. A 
search strategy was constructed for each database, composed of search terms to 
identify papers including older participants, involving supplementation with protein or 
amino acids, a resistance exercise component, and outcomes relating to muscle. A 
search filter was also applied to limit retrievals to studies in humans. An example 
search strategy is included in Table 2.1. The search strategies were applied to 
MEDLINE (1946 to August 2015); EMBASE (1980 to August 2015); CINAHL Plus 
(1937 to August 2015); SPORTDiscus (1949 to August 2015). Additional studies 
were identified by recursive searching of the bibliographies of eligible studies and 
relevant reviews. 
2.2.2 Eligibility criteria 
Studies were screened for eligibility according to the following inclusion criteria: (i) 
Controlled trials in humans; (ii) Trials which implemented a progressive RET regimen 
alongside supplementation with protein or EAA; (iii) Inclusion of a comparison group 
combining RET with either a placebo/non-protein supplement or no supplement at all. 
Studies comparing higher versus lower protein diets were accepted providing the low 





protein (0.8 g.kg-1.day-1) [117]; (iv) Studies including participants with a mean age of 
70 years or over, both healthy and frail; (v) Studies within any publication category 
and all languages; (vi) Outcome measures including muscle strength (primary), 
muscle size, functional ability (defined as the ability to perform everyday tasks and 
activities important for the maintenance of physical independence) and body 
composition (secondary). 
Studies were excluded if the intervention was administered with an agent previously 
shown to result in muscle gains (with the exception of vitamins and minerals). Studies 
involving a specific patient group, or with the aim of treating a clinical condition other 
than frailty or sarcopenia, were also excluded. 
Table 2.1 Example search strategy* 
1 Aged/ or “aged, 80 and over”/ or frail elderly/  
2 Aging/ or longevity/ 
3 (old* adj (adult* or age* or people or person* or population*)).tw. 
4 
(elder* or old* or ?enarian or aged or ag?ing or senior* or geriatric* or 
frail).mp. 
5 1 or 2 or 3 or 4 
6 Muscles/ or muscle, skeletal/ 
7 Exp Muscle Strength/ 
8 Muscle Weakness/ 
9 Muscular atrophy/ or sarcopenia/ 
10 
(musc* adj2 (mass or strength or size or cross sectional area or CSA or thick* 
or power or growth or enlarge* or area or volume or hypertrophy)).tw. 
11 Muscle Development/ 
12 Exercise therapy/ or resistance training/ 
13 (weigh* OR streng* OR resis*) adj2 (train* OR exerc* OR therap*).mp. 
14 Hypertrophy/ 
15 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
16 Exp Dietary Supplements/ 
17 Food, Fortified/ 
18 ((protein* OR amino acid*) adj3 supplement*).tw. 
19 Proteins/ 
20 Exp Amino Acids/ 
21 Exp Dietary Proteins/ 
22 16 or 17 or 18 or 19 or 20 or 21 
23 5 and 15 and 22 
24 Exp animals/ not humans.sh 
25 23 not 24 






2.2.3 Study selection 
Titles were screened for relevance by one reviewer (DKC) and irrelevant titles 
removed, following which abstracts were screened by the same reviewer. For the 
remaining articles, full-texts were obtained via a combination of online databases and 
direct contact with the authors, and these were evaluated to determine whether they 
met the inclusion criteria. Two reviewers (DKC and CAG) independently assessed 
full-texts for eligibility, with a third reviewer (DHS) moderating if necessary. Studies 
deemed eligible were included in the systematic review. 
2.2.4 Data extraction 
Data were extracted from each of the included papers using a standardised data 
extraction form, including the following details of interest; 
(i) Participants: number (total and per group), age, gender, frailty/sarcopenic 
status, baseline protein intake 
(ii) RET regimen: duration, number of weekly sessions, exercise type, 
exercise intensity 
(iii) Protein supplementation: protein type, frequency (daily or with training), 
dose, timing, control treatment, addition of vitamin D 
(iv) Outcome measures: for measures of muscle strength, muscle size, 
functional ability and body composition; where necessary, the required 
data were interpolated from figures or calculated from the reported data. 
Corresponding authors were contacted if this information could not be obtained from 
the paper, and if data could not be obtained, the study (or outcome measure) was 






2.2.5 Summary measures and synthesis of results 
Extracted data were collated and a review was conducted for the primary outcome, 
i.e., muscle strength, as well as the secondary outcomes of muscle size, functional 
ability and body composition. This included description of studies and tabulation of 
data (presented as mean (SD) unless stated otherwise). 
Meta-analysis was conducted on comparable outcomes reported in a minimum of 
two studies. Studies were required to be sufficiently similar to each other in certain 
aspects of study design in order to be included in the same meta-analysis; despite all 
included studies addressing the questions posed by this review, fundamental 
differences in their protocols meant that a number of study combinations were 
unsuitable for meta-analysis. Key criteria for determining study similarity included the 
frequency of protein supplementation (i.e. daily or only on training days), the timing of 
supplementation (including number of doses), the amount of protein supplemented, 
and additional supplementation with vitamin D (which may also influence muscle 
related outcomes [145], with consideration also given to the type of protein 
supplemented and the duration of the study. Where meta-analysis was appropriate, 
effect sizes were calculated (mean differences) with 95% confidence intervals using 
random effects models; forest plots were generated. All calculations were performed 
using RevMan Version 5.2. Risk of publication bias was not assessed using a funnel 
plot when fewer than ten studies were included in each meta-analysis. 
Methodological quality of included studies was assessed using the Physiotherapy 
Evidence Database (PEDro) scale [146]. A score of six or higher indicated moderate 







2.3.1 Study selection 
A total of 11770 articles were identified by the literature search, of which 16 articles 
including 15 studies met all of the inclusion criteria and were included in the 
systematic review [147-162] (Figure 2.1). Two articles [150, 153] reported results 
from the Frail Older People - Activity and Nutrition Study in Umeå (FOPANU), and 
therefore were considered here as one study [150]. 
 













Records identified through database 
searching  






























Records after duplicates removed  
(n = 10199) 
Records screened  
(n = 10199) 
Records excluded  
(n = 10171) 
Full-text articles assessed 
for eligibility  
(n = 28) 
Full-text articles excluded  
(n = 12) 
Reasons for exclusion: 
Participants’ mean age <70 
years: 5 
No suitable comparison: 3 
No relevant outcomes: 2 
No suitable intervention: 1 
No suitable data: 1 
Studies included in 
qualitative synthesis  
(n = 15) 
Studies included in 
quantitative synthesis 
(meta-analysis)  





2.3.2 Participant characteristics 
The 15 eligible studies included 917 participants with a mean age of 77.4 years 
(range 60-100 years) (Table 2.2). Six studies including 400 participants were 
conducted in older adults described as frail, sarcopenic, or mobility limited [147, 150, 
152, 154, 155, 157]. Individuals in the remaining nine studies were categorized as 
healthy [148, 149, 151, 156, 159-163]. Three studies included only male populations 
[148, 151, 161], two included female only populations [154, 159], and the remaining 
10 were mixed populations [147, 149, 150, 152, 155-158, 160, 162]. Of the total 
participants, 32% were male and 68% were female. All studies were published in 
English. 
2.3.3 Interventions 
Resistance exercise regimens varied in frequency from two to five occasions per 
week, with a mean (SD) of 3 (1) per week. Programs lasted between seven weeks 
and one year, with a mean (SD) of 18 (11) weeks. All studies reported a progressive 
exercise regimen; six involved training of the lower limbs alone [147, 148, 150-152, 
162], and the remaining nine comprised both upper and lower limb training [149, 154-
161]. In addition to resistance exercise, participants of five studies undertook co-










Table 2.2 Study characteristics1 




































et al, 1994 
(122) 
50 86.7 Y NA 












17 71.5 N 
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et al, 2006 
(125)2 
91 85.2 Y 
NA 5 d/2wk x 
13 wk 









28 72.0 N 1.10 













Zak et al, 
2009 (127) 
40 78.7 Y NA 















Kim et al, 
2012 (129) 
77 79.2 Y NA 















11-RM, 1-repetition maximum; CHO, carbohydrate; EAA, essential amino acid; LL, lower limb; N, no; RT, resistance training; UL, upper limb; Y, yes. †NA 
indicates studies did not report baseline protein intake.  2Rosendahl et al. 2006 (26) includes Carlsson et al. 2011 (29). 3Approximately 220g (raw weight) or 
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et al, 2013 
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et al, 2013 
(133) 
60 70.0 N 














Daly et al., 
2014 (134) 
100 72.8 N 
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16 74.4 N NA 

















24 84.5 N 1.20 















A total of 10 studies included daily protein supplementation [147-149, 154, 155, 157, 
158, 160-162], one included supplementation on six days per week [159], and in the 
remaining four, participants received supplements only on the day of training [150-
152]. Baseline daily protein intake was reported in eight studies [148, 151, 155-159] 
(Table 2.2), giving a mean (SD) of 1.08 (0.07) g.kg-1.d-1 (range 0.97-1.24 g.kg-1.d-1). 
The amount of protein supplemented varied from 6g per day to 45g per day with a 
mean (SD) of 19 (11) g (Table 2.2).  Eight supplemented groups [150, 151, 155-158, 
160, 161] received protein derived from milk (casein, whey, chocolate milk), one 
group received soy-based protein [147], one group was supplemented with lean red 
meat [159], two studies did not disclose the nature of the protein supplement [149, 
152], two groups received EAA [148, 154] and one group received only leucine [162]. 
Timing of ingestion was inconsistent; in three studies the supplement was 
administered immediately after training [148, 150, 156]; in one study administration 
was immediately before training [152]; in one study half of the supplement was 
administered before training and half after [151]; eight studies administered 
supplements at a consistent time relative to meals [147, 149, 154, 155, 157-159, 
162]; the two remaining studies used a combination of supplementation after meals 
and after training [160, 161]. In addition to protein, six studies also supplemented 
participants with vitamin D [147, 149, 152, 159-161], with reported doses ranging 
from 2-25 μg, and two doses given as approximate proportions of recommendations. 
The studies were highly variable in terms of both study characteristics and outcome 
measures. As a consequence only two studies [155, 157] were sufficiently similar to 







2.3.4 Study quality 
The median overall quality score derived using the PEDro scale was 7/10 (range 4-
10) and the median score for internal validity was 5/8 (range 2-8) (Table 2.3). All 




































































































































































































































































































1. Eligibility criteria were 
specified 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
2. Subjects were 
randomly allocated to 
groups 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
3. Allocation was 
concealed 
N N N Y N N Y Y Y Y Y Y N N N 
4. The groups were 
similar at baseline 
regarding the most 
important prognostic 
indicators 
Y Y Y Y Y Y Y Y Y Y N Y Y Y Y 
5. There was blinding of 
all subjects 
N N N N Y N N Y Y Y Y N N Y Y 
6. There was blinding of 
all therapists who 
administered the therapy 
N N N N N Y N Y Y Y Y N Y N Y 
7. There was blinding of 
all assessors who 
measured at least one 
key outcome 
Y N N Y Y Y Y N Y Y Y N Y N N 
8. Measures of at least 
one key outcome were 
obtained from more than 
85% of the subjects 






1N, criterion satisfied; Y, criterion not satisfied. 2Rosendahl et al. 2006 [125] includes Carlsson et al. 2011 [128]. 
 
initially allocated to 
groups 
9. All subjects for whom 
outcomes were available 
received the treatment or 
control condition as 
allocated or, where this 
was not the case, data 
for at least one key 
outcome was analysed 
by "intention to treat" 
Y N N Y Y N N Y Y Y N Y N N N 
Internal Validity 5 2 2 6 6 5 5 7 8 8 6 5 4 4 4 
10. Results of between-
group statistical 
comparisons are 
reported for at least one 
key outcome 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
11. The study provides 
both point measures of 
variability for at least one 
key outcome 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Statistical Reporting 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
Score/10 
(Criterion 1 is not used 
to calculate PEDro 
score) 





2.3.5 Effect of intervention on outcome measures 
2.3.5.1 Muscle strength 
All 15 studies included in the systematic review included a measurement of muscle 
strength, although a number of different muscle groups were studied (Table 2.4). 
Eleven out of 15 studies demonstrated significant improvements from baseline in 
every measure of muscle strength in all groups undertaking RET with protein/ EAA 
supplementation. Of the remaining studies, one demonstrated significant 
improvements in six of the eight strength measurements included [152], two reported 
significant increases in all measurements except handgrip strength [155, 158], and 
one measured only handgrip strength and reported no change [160]. Three of the 15 
studies reported significant differences between control and supplemented groups, 
with greater improvements in the supplemented groups for measures of knee-
extension strength [154, 159] and hand grip strength [149], and one study reported a 
trend for greater improvement in leg flexion strength [162]. A meta-analysis of data 
obtained from 130 participants across the two comparable studies measuring leg 
press strength showed no statistically significant difference in leg press strength 
between groups (mean difference: 4.9 kg; 95% CI: -10.8, 20.6; P = .54) (Figure 2.2a). 
2.3.5.2 Muscle size 
Eight studies investigated the effect of supplementation on muscle size (Table 2.4). 
Six studies measured thigh muscle cross sectional area (CSA) using computed 
tomography (CT), another measured mid-arm, calf and hip circumference and the 
other measured mid upper arm muscle area, triceps skinfold and calf circumference. 
All but one of the studies which used CT to measure CSA reported significant 





significant differences between the groups. No changes were reported in any other 
measure of muscle size. No measures of muscle size were suitable for meta-
analysis. 
 
Table 2.4 Summary of outcome measures and significant results1 




al., 1994 (122) 
Muscle 
strength  
Muscle size  
Functional 
ability  
1-RM leg strength (sum of L/R knee and hip 
extensors) 
Thigh muscle CSA 
Self-paced gait velocity 
NS 





Muscle size  
Knee-extensor isometric and isokinetic MVC; 1-
RM bilateral knee-extension 
Right thigh whole muscle CSA 
NS 










L/R bicep isometric strength; L/R knee-extensor 
isometric strength;  L/R handgrip strength 
Mid arm, hip and calf circumference 
12-minute walk capacity 
FFM; FM 
RH grip strength (P = 
.031) 
Rosendahl et 





1-RM leg press 
Balance test; self-paced and maximum gait 
velocity; chair-stand test 
NS 




Muscle size  
Body 
composition  
1-RM leg press; 1-RM leg-extension 
Quadriceps muscle CSA 
LBM; FM; % FM; leg LTM; leg % FM 
NS 







L/R 1-RM knee-extension; L/R 1-RM knee 
flexion; L/R 1-RM hip extension; L/R 1-RM hip 
knee flexion 
6-minute walk capacity; POMA 
NS 
Carlsson et 
al., 2011 (128)2 
Body 
composition 
MM (intra cellular water proxy) NS 









Self-paced and maximum gait velocity 
Total MM; appendicular MM; leg MM 
Knee-extension strength 













1-RM leg press; 1-RM leg-extension; handgrip 
strength 
SPPB 
LBM; FM; appendicular LTM 
LBM (P = .006); 
appendicular LTM (P < 
.001); FM (P = .001) 
Arnarson et 







Knee-extensor isometric MVC 
Timed up-and-go; 6-minute walk capacity 
LBM; appendicular LTM 
NS 










1-RM leg press; L/R 1-RM knee-extension 
Total muscle CSA of non-dominant thigh 





al., 2013 (133) 
Muscle 
strength  





1-RM leg press; 1-RM leg-extension; handgrip 
strength 
Quadriceps muscle CSA 
5x chair rise time 
LBM; FM; % FM; leg LTM; leg FM 
NS 










Femur muscle CSA 
4-square step test; timed up-and-go; 30-s chair 
rise test 
Total body FM; body fat percentage; LBM; arm 
LTM, leg LTM 
Leg extension strength  
(P = .010); 
LBM (P = .007); 
leg LTM (P < .05) 







6-minute walk capacity; 30-s chair rise test 
NS 




1-RM leg press; 1-RM leg-extension; 1-RM 
chest press; Knee-extension isometric MVC 
NS 








Leg flexion overcoming isometric strength 
Mid upper arm muscle area; triceps skinfold; calf 
circumference 
Balance test; TUG; 5x chair rise time; 4m walk 
time 
Leg flexion (P = .056) 
 
1NS indicates no significant differences between the RET and protein supplement and RET only 
groups. For significant results, the outcome measure and P-value, where available, are reported. 1-
RM, 1-repetition maximum; CSA, cross-sectional area; FFM, fat free mass; FM, fat mass; L/R, right 
and left; LBM, lean body mass; LTM, lean tissue mass; MM, muscle mass; MVC, maximum voluntary 
contraction; RH, right hand; POMA, Performance Oriented Mobility Assessment; SPPB, Short Physical 
Performance Battery. 2Rosendahl et al. 2006 [125] and Carlsson et al. 2011 [128] report results from 





2.4.5.3 Functional ability 
At least one functional ability outcome was assessed in 12 out of the 15 included 
studies, with 27 outcomes assessed in total (Table 2.4). There was much 
heterogeneity among outcome measures, which included chair rise ability (six 
studies), gait velocity (five studies), walking capacity (four studies), the Timed Up and 
Go (TUG) test (three studies), balance tests (two studies), stair climb speed (one 
study) and the 4-square step test (one study). Three studies included a ’composite’ of 
some of these physical performance indicators; two used the Short Physical 
Performance Battery (SPPB) which combines balance, gait speed and chair rise 
ability [164], and one used Tinetti’s Performance Oriented Mobility Assessment 
(POMA) test combining balance and gait [165]. Of the 27 functional ability 
measurements, 21 were significantly improved after the intervention period, although 
none of these improvements were significantly different with protein/ EAA 
supplementation compared with non-supplemented controls. A meta-analysis of 
SPPB data from two studies indicated no difference between groups (mean 
difference: 0.3; 95% CI: -0.3, 0.9; P = .36) (Figure 2.2b). 
2.4.5.3 Body composition 
Body composition was assessed in nine studies (Table 2.4). Body composition was 
assessed using dual energy X-ray absorptiometry (DXA) in all studies except two; 
one of which used a segmental multifrequency bioelectrical impedance analysis (BIA) 
technique, and the other used bioelectrical impedance spectroscopy (BIS). 
Measurements included total lean body mass (LBM) in six studies; total body fat 
mass (FM) in six studies; percentage FM in three studies; estimated total muscle 
mass (MM) in two studies; fat free mass (FFM) in one study. A number of studies 





(LTM) in three studies; appendicular LTM in two studies; estimated appendicular MM 
in one study; estimated leg MM in one study; leg FM and percentage FM in one 
study; arm LTM in one study. Of the 28 measurements of body composition, six 
demonstrated no significant change during the studies. Improvement in body 
composition with no difference between treatment groups was shown in 17 
measurements, although within-group analysis of two of these measurements within 
one study indicated a significant decrease in total FM and body fat percentage in the 
protein supplemented group but not the control group [159]. Five measurements from 
two studies indicated significant differences between groups [155, 159], with greater 
increases in LBM, leg LTM, appendicular LTM and FM in the supplemented groups 
compared to the exercise-only controls. Meta-analyses of two studies indicated no 
difference between groups for measures of LBM (mean difference: 1.6 kg; 95% CI: -
1.46, 4.6; P = .31) or FM (mean difference: 0.2 kg; 95% CI: -2.3, 2.9; P = .86) (Figure 













(a) leg press strength (mean difference: 4.9 kg; 95% CI: -10.8, 20.6; p = .54) 
(b) SPPB (mean difference: 0.3; 95% CI: -0.3, 0.9; p = .36) 






(d) FM (mean difference: 0.2 kg; 95% CI: -2.3, 2.9; p = .86).  
Figure 2.2 Forest plot of random effects meta-analysis on (a) leg press strength; (b) SPPB; (c) LBM; (d) FM. Mean difference between intervention and 
control groups is represented by the shaded squares, with horizontal lines indicating 95% confidence intervals. The size of each square is indicative of the 










This systematic review presents evidence from 15 studies investigating the additive 
effects of RET and protein supplementation on skeletal muscle strength and size, 
body composition and functional ability in older adults. Studies reported overall 
improvement from baseline for the majority of outcomes, indicating a positive effect of 
RET. However, across the 15 studies these improvements were not significantly 
different in groups receiving protein/ EAA supplements and undergoing RET 
compared with RET alone, indicating no additional effects of supplementing with 
protein. Although limited, the meta-analyses of comparable outcomes found no 
statistically significant differences, supporting this conclusion. 
A previous systematic review has shown that older muscle demonstrates an adaptive 
response to RET across a range of outcomes [166], hence RET alone is considered 
an effective strategy for combatting sarcopenia. Given the anabolic properties of both 
resistance exercise and protein/EAA ingestion, it is plausible that the combination of 
these factors in a chronic intervention may have an additive effect, and so enhance 
the responses shown with RET alone. Certainly, this has been shown to be the case 
in younger adults [140]. Although individual significant results in strength and body 
composition outcomes are reported in the present review, the overall results indicate 
that this does not hold true for older adults. 
This overall absence of an additive effect, in contrast to that of younger adults, may 
be a result of the mechanisms of anabolic resistance in older muscle. For example, 
the expression and activation of proteins responsible for EAA sensing and signalling 
are reduced in older people [56], meaning the extent to which the subsequent 
cascades can be activated is limited, causing a blunted anabolic response compared 





the upstream signal (i.e. more amino acids) will not result in any additional response. 
Where reported, all baseline protein intakes were within the RDA, and with lower 
sensitivity to higher protein intakes, this may have been sufficient to elicit a maximal 
protein synthetic response in combination with RET, prior to any supplementation. 
Certainly, there is evidence to suggest that there is no benefit for older adults in 
consuming more than the RDA for protein; in a 12-week trial of adults aged 50-80 
years daily protein intake was increased from 0.9 g.kg-1.day-1 to 1.3 g.kg-1.day-1 with 
no additional response to RET [123]. Furthermore, when the effects of consuming the 
RDA were compared with a higher protein dose in older adults performing RET, the 
metabolic adaptations to increased protein intake actually reduced the utilization of 
protein [167]. However, a recent study in older men measured phosphorylation of the 
anabolic signalling molecule p70S6K as an indicator of mTOR pathway activation, in 
response to a range whey protein doses between 0-40g following a bout of 
resistance exercise [168]. Phosphorylation was correlated with protein dose, which 
indicates a dose-response relationship in the acute setting. As this relationship does 
not appear to translate to a chronic setting, this suggests that the mechanisms of this 
anabolic effect require further investigation. 
The alternative protein intake recommended for older adults by the PROT-AGE study 
group offers a slightly different perspective [119]. If the findings of this review are 
considered in terms of this range of 1.0-1.2 g.kg.-1day-1, most included studies were 
above the lower limit of this recommendation, and so the idea that baseline intakes 
were sufficient to maximally stimulate MPS would still apply. However, baseline 
intakes in two studies, while meeting the RDA, were at or below the alternative 
recommendation [155, 157], and the supplemented groups in these two studies 





studies also fell into the small number which gave a significant difference in LBM 
between supplemented and control groups [155], and the other reported a significant 
difference in leg press peak power [157]. Although not included as an outcome of the 
review, muscle power is highly relevant in this context, as it is dependent upon 
muscle mass and also declines with ageing, impacting upon functional ability [27, 
169]. This suggests that, under circumstances of lower baseline protein intake, there 
may be potential for an additive effect of RET and protein supplementation. This is of 
particular relevance to older adults who are frail or in institutionalised care, as protein 
intakes for these groups have been found to be lower than community dwelling older 
people, at 1.0 and 0.8 g.kg-1.day-1 respectively [170]. 
In addition to the total daily protein intake, the influence of protein supplementation 
with respect to the size of an individual dose of supplement should be considered. 
Acute studies have demonstrated that older adults require a bolus of at least 20-40g 
of protein after resistance exercise to stimulate the MPS level above that of an 
exercised, unfed state [60, 106]. The studies included in this review used a range of 
protein doses, some of which were at or above thresholds previously found to be 
effective in an acute setting to increase MPS. However, there were no consistent 
differences between the results of these studies compared with those utilising lower 
protein doses. Again, acute effects do not appear to translate to a chronic response. 
This also has implications for total protein intake recommendations for older adults 
conducting regular exercise, which are partially based on this acute evidence. It is 
recommended that older adults in this category require more protein than their 
inactive counterparts, and that they should consume at least 1.2g.kg-1.day-1 including 





that, from the perspective of improvements in muscle mass and function, there may 
not necessarily be any benefit from the increased protein intake. 
The efficacy of protein supplementation in addition to RET has been addressed by 
previous systematic reviews, with contrasting results. Cermak et al. (2012) found in 
favour of an additive effect in terms of FFM and muscle strength, concluding that 
protein/EAA supplementation augmented responsiveness to RET in both older and 
younger participants, a discrepancy most likely due to the different criteria used to 
define older populations [140]. A mean age of at least 70 years was required for 
studies to be included in the present review, giving an overall mean age of 77.4 years 
and a range of participant ages between 60 and 100 years, whereas the older cohort 
included in the previous review was aged between 48 and 72 years. The previous 
review was also restricted to only healthy participants, while the present review 
included participants defined as frail or sarcopenic, and in fact only one study was 
common to both reviews [151]. More recently, Finger et al. (2015) considered the 
effects of RET and protein supplementation in older adults in terms of FFM and 
muscle mass and strength [142]. Again, the lower age limit was younger than that of 
the current review at 60 years, and included studies with participants as young as 50 
years. Of the nine included studies five were also included in the present review, with 
the remaining four excluded at either the abstract or full text screening stages due to 
the age criterion. Meta-analysis indicated a significant effect on FFM, which may 
again be a result of inclusion of younger participants. The meta-analysis is an area in 
which the methodology differed from the current review; previously, all studies with 
comparable outcomes were included in meta-analyses, however in this review any 
prior decision to include studies in a meta-analysis was on the basis of similarity of 





the studies were truly comparable. Further methodological differences also allowed 
the current review to provide a more comprehensive view of the subject; a more 
extensive list of outcome measures includes measures of functional ability, which are 
highly relevant when considering the practical effects of an intervention, as well as a 
greater range of body composition outcomes. Furthermore, the eligibility criteria for 
the current review were less restrictive, as exclusions were not on the basis of other 
macronutrients in the supplement, allowing a greater number of studies to be 
included. 
In general, the overall quality of the included studies was moderate to high, although 
several studies scored poorly for internal validity. In particular, approximately half of 
studies did not report blinding of all participants, and four failed to use any placebo in 
the control groups, meaning these studies may have been susceptible to 
performance bias.  
2.5.1 Update 
One of the studies included in the review reported results from the Vienna Active 
Ageing Study [160], and since completion of the review, additional results from 
relevant outcomes have been published in a separate article [171]. Additional 
outcomes were isokinetic knee-extensor and flexor strength, an arm lifting test and a 
functional reach test. All measurements increased significantly over time with RET 
(p<.05), however there was no significant difference between supplemented and non-
supplemented groups. 
Recently, an additional systematic review of the influence of protein supplementation 
on RET efficacy has also been published [141]. Data from 49 studies were included 





and older subgroups defined as below and above 40 years. Outcome measures were 
muscle strength, FFM and muscle size. Consistent with previous reviews, 
improvements with RET were reported for all outcomes, which were significantly 
enhanced by the addition of supplementation with mean differences of 2.49 kg for 1-
RM strength, 0.30kg for FFM, 310 μm2 for muscle fibre CSA, and 7.2 mm2  for mid-
femur CSA (p<.05). As well as meta-analysis, data analysis included a meta-
regression using several variables as covariates, including age of participants. 
Results indicated decreasing efficacy of protein supplementation on FFM with 
increasing age (k=.002), which is consistent with the lack of effect reported here. The 
authors suggest that this age effect may be due to the amount of protein consumed; 
while older adults require higher protein doses to stimulate MPS [100], the average 
supplemental dose was lower in the studies of older adults compared with young (20 
g vs 42 g). Similarly, mean supplemental dose in the current review was 19 g, and so 
this explanation may also be applied to the results presented here, although the 
possible influence of low baseline protein intake suggested here was not supported 
by this new review. 
As with previous reviews in this area, when conducting subgroup analysis for older 
participants a relatively young cut-off of 45 years was used. Hence, while the meta-
regression provided insights into the effect of ageing on the efficacy of protein 
supplementation, arguably the results of the subgroup analysis do not truly reflect 
that of older adults. Again, no measures of functional ability were included. 
2.5.2 Limitations 
The greatest limitation of this review is the lack of meta-analysis data. Outcome 
measures showed a high degree of heterogeneity and data were not presented 





supplementation, training protocols and duration of intervention. As a result, 
comparable outcome measures were limited, and differences in methodology meant 
that comparisons between most studies would not have been valid. Ideally, subgroup 
analysis would have been completed, for example for frail/sarcopenic and healthy 
groups, and for different distributions and timings of protein intake as the number of 
doses and proximity to exercise may have affected the response, but methodological 
differences did not allow this. However, the vast majority of results indicate no 
additional effect of protein supplementation, and this did not appear to differ 
according to population or protocol characteristics, other than that of baseline protein 
intake discussed above.  
The review may also be limited by the sample sizes of the included studies, some of 
which were relatively low and therefore may have lacked sufficient power to identify 
small differences between groups. Eight of the studies [150, 152, 154-159] reported a 
power calculation which deemed the sample size to be adequate, and there was no 
difference in terms of significant results between these and the studies which did not 
report a power calculation. However, the majority of these were powered for only 
selected outcome measures, usually body composition, meaning the sample sizes 
may not have been sufficient for other outcome measures; this is particularly 
important to consider with respect to more complex outcomes, such as measures of 
functional ability, which may require larger sample sizes to detect significant 
differences. 
2.5.3 Conclusions 
Protein/ EAA supplementation does not significantly augment the effects of 
progressive RET in older adults in terms of muscle strength, muscle size, body 





of RET regimens to maintain and increase muscle mass and strength in older 
populations, which may help to combat sarcopenia and frailty.  
The findings also suggest that there may be an additional benefit of protein 
supplementation and RET programs in frail older adults who do not regularly 
consume sufficient protein, particularly those in institutionalized care. Thus, future 
research may consider exploring this by conducting trials placing greater emphasis 
on the baseline protein intake of participants. Likewise, little discussion has been 
given here to the protein supplement characteristics, such as the amount, timing and 
distribution of ingestion, and further research may investigate these areas to fully 









3. SYSTEMATIC REVIEW: RESPONSIVENESS OF SKELETAL MUSCLE TO 
PATTERN OF DAILY PROTEIN INTAKE IN OLDER ADULTS 
Objective: Systematically review the literature to investigate the influence of the 
pattern (timing and/or distribution) of daily protein intake on skeletal muscle in older 
adults.  
Methods: Systematic search strategies were applied to MEDLINE, EMBASE, 
SPORTDiscus, and CINAHL Plus in December 2013, to include studies in adults 
aged ≥ 65 years, comparing at least two patterns of protein intake differing in timing 
and/or distribution. Data were extracted for measures of body composition, muscle 
strength and size, functional ability, nitrogen balance and protein turnover. 
Quantitative synthesis and meta-analysis were conducted on comparable outcomes. 
Results: Six studies including 135 participants were identified. Two compared even 
and uneven distributions of daily protein intake, and four compared timing of a protein 
supplement relative to an exercise intervention. Changes in body composition, 
nitrogen balance and protein turnover were significantly greater with the uneven 
distribution. Comparison of timing studies was problematic due to variable protocols; 
meta-analysis was possible of two studies measuring nitrogen balance but there was 
not significant difference treatments (mean difference: 0.52; 95% CI -0.32, 1.35; p = 
.23). 
Conclusions: Evidence relating to the influence of timing and distribution of protein 









Despite its anabolic properties, the role of dietary protein in interventions to protect 
against sarcopenia is unclear. Evidence of the effects of increased protein intake is 
mixed, and as indicated by the systematic review in Chapter 2, there do not appear 
to be any additional benefits of protein supplementation in older adults undertaking 
RET. Due to the response profile of muscle protein synthesis (MPS) to protein 
ingestion, it has been proposed that the delivery of dietary protein, rather than the 
total daily amount, may influence the response. 
The acute anabolic response to a dose of protein is transient, persisting for 
approximately two hours, and demonstrates a dose-dependent relationship which is 
saturable beyond a certain protein dose. Hence, the total anabolic response over the 
course of a day may be affected by both the timing of intake, and the distribution of 
protein into doses. As discussed in Section 1.4.4, there is some evidence of an effect 
of protein distribution; younger adults have exhibited changes in the rate of MPS with 
different protein distributions, for example Mamerow et al. (2014) reported 25% 
greater 24-hour MPS following seven days of consuming 90 g.day-1 protein as an 
evenly spread distribution compared with a uneven intake [130]. Furthermore, 
associations have been found between habitual protein distribution and indicators of 
muscle health in older adults; more even distribution of protein across the day was 
associated with greater muscle strength and lean mass, and lower frailty scores [133, 
134]. However, experimental evidence of the effects of protein distribution on muscle 





In terms of the timing of a dose of protein, again the effects are unclear. There has 
been a particular interest in the timing of protein supplementation relative to a bout of 
exercise, however despite a number of studies there is no consensus even in 
younger adults [172]. For example, greater MPS has been demonstrated with EAA 
and carbohydrate supplementation before, rather than after, resistance exercise 
[173], however no such effect was found when this was repeated with whey protein 
[174]. Several studies have considered the chronic effects of proximity of protein 
supplements to resistance exercise in terms of training-induced changes in muscle 
strength and body composition, again with mixed results [175, 176]. This indicates 
that the timing of supplementation may be important in younger adults, and so also 
requires consideration in older adults. 
 3.1.2 Aims 
Currently, there is limited evidence to suggest an effect of protein intake pattern on 
skeletal muscle size and function in older adults, and no consensus as to how this 
may be used to combat sarcopenia. The aim of this systematic review was to 
evaluate the influence of the pattern of protein intake in older adults on measures of 
muscle strength and size, body composition, nitrogen retention, protein turnover and 
functional measures. 
3.2 Methods 
This systematic review was conducted according to a pre-defined protocol informed 
by the Cochrane Handbook for Systematic Reviews of Interventions [177] and is 
reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-





3.2.1 Information sources and search 
Search strategies were designed to include components relating to participant age, 
dietary protein, relevant outcome measures, and timing/distribution. Table 3.1 
includes an example search strategy. 
Searches were conducted by one reviewer (DKC) in December 2013 using the 
following electronic databases (to 11 December 2013): MEDLINE (from 1946); 
EMBASE (from 1980); CINAHL Plus (from 1937); SPORTDiscus (from 1949). 
Recursive bibliography searching of included articles was also performed.  
3.2.2 Eligibility criteria 
Articles were assessed for eligibility according to the following criteria; (i) conducted 
in adults aged ≥65 years (or mean age ≥65 years); (ii) a chronic intervention (i.e., 
more than one discrete bout) related to the timing and/or distribution pattern of 
protein/EAA ingestion; (iii) comparison with at least one alternative protein/EAA 
intake pattern differing in the timing and/or distribution of doses, or normal care (i.e. 
no treatment); (iv) measurement of at least one of muscle strength, muscle size, body 
composition, nitrogen balance/retention, protein turnover/synthesis/breakdown and 
functional ability. Articles were excluded if they were (i) administered to a specific 
patient group or (ii) used with the intention of treating a specific health condition other 
than frailty or sarcopenia. Unlike the systematic review in Chapter 2, an exercise 
component was not required for eligibility as this was primarily a study of protein 







Table 3.1: Example Ovid MEDLINE (R) search strategy1 
1 Aging/ 
2 Exp aged/ 
3 (65 adj2 (years or age* or old*)) 
4 (old* adj (adult* or people or person* or population* or men or women)) 
5 (elder* or senior* or geriatric* or ?enarian or ag?ing) 
6 (age* or aging or old* or elder*) adj1 (musc*)) 
7 1 or 2 or 3 or 4 or 5 or 6 
8 Proteins/ 
9 Exp Amino Acids/ 
10 Exp Dietary proteins/ 
11 ((protein* or amino acid*) adj3 (intake or requirement)) 
12 ((protein* or amino acid*) adj3 (supplement* or feeding or ingest*) 
13 8 or 9 or 10 or 11 or 12 
14 Muscle Development/ 
15 Muscle, Skeletal/ 
16 Muscle Strength/ 
17 (musc* adj2 (function* or power or strength)) 
18 (musc* adj2 (grow* or hypertrophy or size or mass or csa or cross sectional area or volume)) 
19 Body Composition/ 
20 (lean adj3 mass) 
21 (protein adj2 (turnover or synthesis or breakdown)) 
22 (nitrogen adj2 (balance or turnover or synthesis or breakdown or retention or loss or retain*)) 
23 Sarcopenia/ 
24 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 
25 Meals/ 
26 ((pulse or bolus or spread) adj2 (feeding or ingest* or intake or pattern)) 
27 ((ingest* or feeding or meal* or intake or provision or administration) adj2 (pattern or timing* or time* 
or distribution*)) 
28 ((distribution* or timing*) adj3 (protein* or amino acid*)) 
29 25 or 26 or 27 or 28 
30 7 and 13 and 24 and 29 
31 Filter 30 – humans 
32 Remove duplicates from 31 
1Ovid MEDLINE (R) search, adapted for other databases 
 
3.2.3 Study selection 
Following duplicate removal, search results were screened by one reviewer (DKC) to 
determine eligibility according to the criteria, firstly on the basis of Title and then 
Abstract. Full texts were obtained for all articles which could not be excluded on the 
basis of Title and Abstract, and two reviewers (DKC and CAG) assessed these full 





eligible on the basis of the full text. Any disagreements were resolved upon further 
discussion.  
3.2.4 Data extraction 
Data were extracted by one reviewer (DKC) using a standardised data extraction 
sheet. Data relating to the following items were extracted; 
(i) Study design and duration 
(ii) Participant: number (total and group), age, gender, health status 
(iii) Intervention details: protein/EAA doses and timings, exercise type, intensity 
and frequency (when applicable) 
(iv) Outcome measures: a definition of the outcome, the method of 
measurement, results from each study group and the presence or absence 
of a statistically significant difference between groups. These data were 
extracted for measures of muscle strength, muscle size, body composition, 
nitrogen balance/retention, protein turnover/synthesis/breakdown and 
functional ability 
3.2.5 Summary measures and synthesis of results 
Extracted data were summarised using qualitative methods, including description of 
studies and tabulation of results. Meta-analysis was conducted on comparable 
outcome measures from studies using similar interventions (RevMan Version 5.2). A 
fixed effect meta-analysis model was used for data from functionally similar studies, 
and for continuous data measured using the same scale the effect size was 
expressed as a mean difference with 95% confidence intervals [178]. Analyses were 





deviations were estimated from statistics or figures presented in the published 
articles [179]. 
3.2.6 Risk of bias 
Two reviewers (DKC and CAG) independently assessed internal validity of the 
studies with moderation by a third (AR) when necessary. The Cochrane ‘risk of bias’ 
assessment tool [180] was used, as recommended by the Cochrane Handbook for 
Systematic Reviews of Interventions. It was acknowledged that blinding of 
participants and personnel would not be feasible for certain interventions, such as 
those which altered the distribution of total daily protein/EAA intake, but that it was 
unlikely to affect physiological measures such as nitrogen balance. Such judgements 
are permitted within the Cochrane tool, as assessment includes evaluating the likely 
effect of a lack of blinding. 
Risk of bias across studies could not be addressed using a funnel plot to identify 
publication bias since fewer than 10 studies were included in the review [181]. 
Selective reporting was assessed within the Cochrane ‘risk of bias’ tool [180]. 
3.3 Results 
3.3.1 Study selection  
The literature search identified 159 articles. Following the removal of duplicates and 
ineligible articles, six studies were included in the review [182-187] (Figure 3.1). 
Within one of the articles, trials were carried out in two cohorts of participants, under 
hypocaloric and hypercaloric conditions [186]. As the trials were performed in 


















3.3.2 Participant characteristics  
A total of 135 participants with a mean age of 75.5 years were included in the 
analysis (Table 3.2), and the mean (SD) sample size was 23 (21). Two studies were 
conducted in only male participants [183, 184], one in female participants [182], and 
the remaining three used mixed cohorts, giving 47% male and 53% female 
participants. Five studies investigated healthy participants, however in one study 
(n=63) participants were hospitalised and judged to be malnourished or at risk of 
malnourishment (i.e. scored <23.5 on the Mini Nutritional Assessment) [187]. Two 
used a crossover design [185, 186] and the remaining studies were of a parallel 
group design. 
3.3.3 Interventions 
There was a clear division in terms of the interventions used, and the studies were 
therefore considered in two separate groups (Table 3.2).  
In the first group, the distribution of total daily protein intake was manipulated [182, 
187]. Protein was given in an even, or ‘Spread’, diet, as four equal or similar doses, 
compared with an uneven, or ‘Pulse’, diet in which approximately 80% of protein was 
consumed in a single dose at noon and the remainder spread over a further two or 
three meals. The studies differed in duration, from 14 days [182] to six weeks [187]. 
Both studies based the experimental diets on participants’ usual dietary habits, 
however one also included supplementation with milk powder to enhance protein 
content [187]. 
The four studies in the second group compared different timings of protein 





training (RET) programmes; Esmarck et al. (2001) supplemented either immediately 
or two hours after exercise [183], while Candow et al. (2006) compared 
supplementation immediately before and after exercise, as well as a placebo group 
[184]. In the remaining two studies participants completed aerobic exercise, and were 
given 2 x 3-day protein timing interventions in a crossover design [185, 186]. 
Supplements were given either as a carbohydrate drink in the morning and a protein 
drink immediately after exercise in the afternoon, or in the comparison intervention 
these drinks were reversed (i.e., protein in the morning and carbohydrate in the 
afternoon). In all exercise studies supplements were given in liquid form; 15g doses 
of a milk and whey protein combination were given in both aerobic exercise studies 
[185, 186], Esmarck et al. (2001) gave 10g of a commercial protein supplement 
containing milk and soy proteins [183], and Candow et al. (2006) gave 0.3g.kg-1 body 










Table 3.2: Study characteristics1 
Distribution studies 
Author, year N Mean age Study design Daily protein distributions Duration 
Arnal et al., 1999 
(157) 
15 68 Parallel PULSE:  7, 79, 14% SPREAD: 25, 25, 25, 25% 14 days 
Bouillanne et al., 
2013 (162) 
63 85 Parallel PULSE:  6, 78, 2, 13% SPREAD: 20, 30, 20, 30% 6 weeks 
Exercise studies 
Author, year N Mean age Study design Exercise protocol Protein dose Protein timings Duration 
Candow et al., 
20062 (159) 
19 65 Parallel 
RET 








Esmarck et al., 
2001 (158) 
13 74 Parallel 
RET 
3 x 30 min per week 
10g 
P0: immediately after 
training 
P2: 2 hours after 
training 
12 weeks 
Jordan et al., 2010 
(160) 
9 65 Crossover 
Aerobic cycling 
1 hour per day 
15 
g 
PRO: after training  
(CHO drink in morning) 
CHO: in morning 
(CHO drink after 
training) 
3 days 




6 65 Crossover 
Aerobic cycling 
1 hour per day 
15g 
PRO: after training  
(CHO drink in morning) 
CHO: in morning 
(CHO drink after 
training) 
3 days 
1RET, resistance exercise training 
2Study also included non- protein supplemented control group, given placebo drinks 







3.3.4 Outcome measures 
No outcome measures were common to both intervention studies (Table 3.3). Arnal 
et al. (1999) measured fat mass (FM) and fat free mass (FFM) using H218O, as well 
as nitrogen balance and protein turnover. Bouillanne et al. (2013) included three 
different components of body composition; lean body mass (LBM), appendicular 
skeletal muscle mass (ASMM) and body cell mass (BCM) indices, all using dual-
energy X-ray absorptiometry (DXA) and/or bioelectrical impedance analysis (BIA), as 
well as hand grip strength, and activities of daily living (ADL) as a measure of 
functional ability [187]. 
Of the four timing and exercise studies, both RET studies included measures of body 
composition, muscle strength and muscle size, however each measured different 
components using different techniques (Table 3.3) [183, 184]. Additionally, one study 
included urinary 3-methylhistidine excretion as an indicator of protein breakdown 











Table 3.3: Summary of outcome measures and significant results1 
Author, year Outcome measures Significant results 
Arnal et al., 1999 (157) Body composition 
Nitrogen balance 
Protein turnover 
FM, FFM (isotopic dilution measurement) 
5-day intake and output 
3-day average and fed-state synthesis and 
breakdown (isotopic nitrogen measurement) 
FFM change: PULSE >  SPREAD (p < .05) 
Nitrogen balance: PULSE >  SPREAD (p < .05)  
Protein turnover: PULSE >  SPREAD (p < .05) 







LBM, ASMM, BCM indices (DXA measurement) 
ADL 
LBM change: PULSE >  SPREAD (p = .01) 
ASMM: PULSE >  SPREAD (p = .01) 
BCM: PULSE >  SPREAD (p = .002) 






Leg press strength, bench press strength 
LBM (air displacement plethysmography 
measurement) 
Elbow, knee and ankle flexor thickness 
Elbow, knee and ankle extensor thickness 
Urine 3-methylhistidine levels 
NS 




LBM (DXA measurement) 
Quadriceps femoris CSA 
 
CSA change: P0 > P2 (p < .01) 
LBM: P0 > P2 (p < .05) 
Jordan et al., 2010 (160) Nitrogen balance 3-day intake and output 
 
Nitrogen balance: PRO > CHO (p < .05) 
Minor et al., 2012 (161) 
 
Nitrogen balance 3-day intake and output 
 
Nitrogen balance: Trend for PRO > CHO (p = .09) 
1FM, fat mass; FFM, fat free mass; LBM, lean body mass; ASMM, appendicular skeletal muscle mass; BCM, body cell mass; DXA, dual-energy X-ray 








3.3.5 Effect of interventions on outcome measures 
The results relating to the two groups of studies are reported separately. Within each 
group there were few comparable outcome measures and the majority of the analysis 
is quantitative. A summary of results and significant p-values is presented in Table 
3.3. One outcome measure of nitrogen balance was suitable for meta-analysis in two 
studies of timing of protein relative to exercise, both including low participant 
numbers [185, 186]. 
3.3.5.1 Distribution studies 
Both distribution studies reported significant effects of distribution on body 
composition [182, 187]. Arnal et al. (1999) reported within group results showing a 
decrease in FFM over two weeks with the Spread diet but no change with the Pulse 
diet, and a significant difference between groups in terms of change in FFM in favour 
of the Pulse diet [182]. The two treatment groups did not differ with respect to change 
in FM. The results of Bouillanne et al. (2013) showed significantly greater increases 
in LBM, ASMM and BCM indices with the Pulse diet compared with the Spread diet 
[187]. 
Only Arnal et al. (1999) measured nitrogen balance and protein turnover [182]. 
Nitrogen balance was significantly greater with the Pulse diet compared with Spread. 
Twenty-four-hour protein turnover was also greater with the Pulse diet, and 
measurements of postprandial protein turnover indicated greater protein gains with 
the Pulse diet compared with Spread. 






3.3.5.2 Timing with exercise-supplement studies  
One study reported greater LBM increases with protein supplementation immediately 
after exercise (P0) compared with supplementation two hours after exercise (P2), 
and a significantly greater increase of 3.7 cm2 in quadriceps femoris cross-sectional 
area (CSA) with the P0 intervention compared to P2 [183]. The change in knee-
extension strength did not differ between treatment groups for the majority of 
measurements, although there was a trend (p = .07) for greater gains in isokinetic 
strength at 60deg.s-1 in the P0 group compared to P2. Another study reported a 
greater increase in muscle thickness of elbow, knee and ankle flexors in one 
supplemented group compared with the placebo group [184]. However, there were 
no significant differences between protein supplemented groups in any of the 
included measures of strength, muscle thickness, LBM or protein breakdown. 
Of the two studies measuring nitrogen balance with aerobic exercise, one reported 
significantly greater results when the protein supplement was ingested immediately 
after exercise compared with supplementation in the morning [185], while the other 
reported a trend in the same direction (p = .09) [186]. However, the meta-analysis 
(fixed effects; mean difference: 0.52; 95% CI: -0.32 to 1.35) did not show a significant 















Figure 3.2: Fixed effects model on 3-day nitrogen balance (mean difference: 0.52; 95% CI: - 0.32 to 1.35, p = 0.23). Forest plot illustrating the mean 
difference between the PRO and CHO groups (squares), 95% confidence intervals (horizontal lines) and mean difference (diamond). The size of each square 











3.3.6 Risk of bias 
For all studies the majority of components could only be judged as unclear due to a 
lack of reported information (Table 3.4), however all studies had at least one high risk 
component and therefore were evaluated to be at high risk of bias. The most 
common reason for this judgement was a lack of usual care/control group, and, for 
the crossover studies, the absence of a washout period between interventions. All 
studies were included in the analysis to provide an overview of results, as no low risk 
studies were available.  
Selective reporting was identified in one study. The outcome measurements of 
Bouillanne et al. (2013), as listed under a clinical trials registry, included plasma 
amino acid levels as a secondary measure, however these results were not 








Table 3.4: Summary assessment of overall risk of bias for each study1 
Author, year 
Components of risk of bias 
Summary Comments on high risk components 
1 2 3 4 5 6 7 
Arnal et al., 
1999 (157) 




One high risk component: 7 
No primary outcome specified 
No usual care control group 
Bouillanne et 
al., 2013 (162) 




Two high risk components: 6, 7 
Protocol available at http://clinicaltrials.gov, plasma amino acids listed as 
secondary measure but results not reported 
No usual care control group 
Candow et al., 
2006 (159) 




One high risk component: 7 
Difference in baseline protein intake between groups, possibility of effect on 
results not addressed 
Esmarck et al., 
2001 (158) 




One high risk component: 7 
No primary outcome specified 
No non-protein control group 
Jordan et al., 
2010 (160) 




One high risk component: 7 
No washout period 
No non-protein/protein only control group 
Minor et al., 
2012 (161) 




One high risk component: 7 
No washout period 
No non-protein/protein only control group 
1Components of risk of bias criteria: 1, sequence generation; 2, allocation concealment; 3, blinding of participants/personnel; 4, blinding of outcome 
assessment; 5, Incomplete outcome data; 6, selective outcome reporting; 7, other potential threats to validity. Levels of risk of bias: H, high risk of bias; U, 






The aim of this review was to establish whether the responsiveness of older muscle 
to protein ingestion is affected by the timing and/or distribution pattern of protein 
intake. Data from only six studies including 135 participants were eligible for 
inclusion, indicating a lack of research in this area. Studies were categorised into one 
of two groups according to a clear distinction in the type of intervention used; two 
studies compared different distributions of total daily protein intake, and four 
compared timings of a protein supplement relative to exercise. Meta-analysis was 
only possible for one outcome measure included in two studies.  All other data 
analyses were qualitative. Some individual results from these studies indicate that 
the responsiveness of older muscle to protein may indeed be affected by the timing 
and distribution of intake, although more specific conclusions cannot be drawn due to 
the limited study comparability. 
All included studies were evaluated as being at high risk of bias, which must be 
considered when interpreting these conclusions. Some issues contributing to this risk 
of bias related to reporting issues, such as the failure to specify a primary outcome or 
report all secondary measures listed in the study protocol. However, a greater 
number of risk of bias components indicate design issues, as only one of the six 
studies included a usual care/control group, and the studies using a crossover design 
did not include a washout period. 
3.4.1 Studies of daily protein distribution 
Both distribution studies implemented a Pulse protein distribution, characterised by 
one very large combined with smaller protein meals, and a Spread distribution 




studies indicate a possible influence on body composition, nitrogen balance and 
protein turnover, and it is noteworthy that the more beneficial results were 
consistently observed in the Pulse intervention groups. This is perhaps surprising 
given other evidence in this area; following 7 days of similar distribution interventions, 
Mamerow et al. (2014) reported greater 24-hour MPS with the even intervention, 
although this was a study of younger adults (37 ± 3 years) [130]. Furthermore, the 
association between frailty and the daily unevenness of habitual protein intake 
reported by Bollwein et al. (2013) would suggest better results with the even 
distribution [133]. The apparent benefits of the Pulse distribution compared with a 
Spread distribution may be explained by considering the amount of protein in each 
individual dose. It is suggested that postprandial MPS is restricted in older age due to 
greater splanchnic extraction of EAA, resulting in lower bioavailability of EAA for MPS 
[188]. Larger protein doses may saturate this splanchnic utilisation, thus enabling 
higher plasma concentrations of EAA to be used in muscle protein synthesis. In the 
case of the protein intake distribution patterns used in the studies by Arnal et al. and 
Bouillanne et al., it is plausible that only the large doses in the Pulse distributions, 
and none of the Spread doses, were sufficient to reach this saturation. 
However, previous research has shown that, rather than continuing to increase with 
greater protein/EAA doses, a plateau is reached with respect to MPS [56, 63], which 
may have implications for these patterns of protein intake. As described above, in a 
study of even and uneven protein distribution patterns in younger adults, Mamerow et 
al. (2014) reported greater MPS following 10 days of the even diet [130]. Crucially, in 
this case the total daily protein intake was ~90g per day, and was divided into three 
meals rather than four, meaning all even doses were approximately 30g. If the dose 




would have stimulated this maximal rate three times a day, and the uneven 
distribution only once. 
When considered in terms of this threshold, the distribution studies included in the 
review give mixed results. As absolute protein doses, for both studies only the large 
Pulse dose reached the 30g threshold, and all of the Spread doses fell below. When 
intakes were standardised for body weight and considered relative to the proposed 
threshold of 0.4 g.kg-1 [100], in one study again only the large Pulse dose of 0.83 
g.kg-1 exceeded the threshold [182]. However, the other study reported two Spread 
doses which approached the threshold at 0.38 and 0.39 g.kg-1 [187]. Given that both 
studies showed greater improvements with the Pulse diet, the influence of this 
maximal MPS protein dose is unclear from these studies. Furthermore, caution must 
be applied with this interpretation of the data, as the concept of a protein dose 
threshold is a controversial one. Studies reporting this threshold effect have generally 
measured only MPS, and less is known about the relationship between protein dose 
and muscle protein breakdown (MPB) due to the greater methodological 
advancements in the measurement of MPS. Through the suppression of MPB, net 
protein gains may continue to increase at greater protein intakes, impacting on total 
muscle accretion [189]. The trajectory of this increase would be important in 
determining the optimal protein distribution. Future research is required to further 
investigate the effect of more frequent maximal stimulation within an even protein 
distribution diet. 
The question of the impact of protein distribution is further complicated by a more 
recent study, published since the searches for this review were completed, and which 
would have been eligible for inclusion. Kim et al. (2015) compared the effects of high 




divided into either even (33, 33, 33%) or uneven (15, 20, 65%) distributions across 
the day, in 20 healthy older adults (aged 52-75 years) [190]. MPS and whole-body 
protein turnover were measured following three days of these interventions. Findings 
indicated that whole-body protein synthesis and net balance, as well as MPS, were 
significantly different between the high and lower protein diets; this is consistent with 
the recommendation that older adults require more protein than the minimum RDA of 
0.8 g.kg-1.day-1 [119]. However, the results also revealed no effect of protein 
distribution at either level of protein intake, despite the higher protein diet being such 
that all even doses would have exceeded the 0.4 g.kg-1 threshold. The authors 
proposed several possible explanations for the discrepancy between these and 
previous results, such as those of Mamerow et al. (2014) described above [130]; the 
increased threshold for older adults may be compounded by varying protein quality 
within the mixed meals of the interventions, meaning the protein doses consumed 
may still have been insufficient to stimulate maximal MPS. There is also a potential 
gender effect on the response to the interventions due to the gender dimorphism in 
MPS which has been demonstrated previously [101] which may have affected 
interpretation of the results, particularly given the relatively small sample sizes. The 
findings were corroborated by a more recently published study, using the same 
distributions of 1.1 g.kg-1.day-1 protein, but this time over eight weeks with outcome 
measures of lean mass, muscle strength and functional outcomes, with a 24-hour 
stable isotope infusion trial to measure MPS before and after the intervention [191]. 
Again, no difference was between distribution groups for any outcome measure. 
These findings would also appear to contradict the findings of this review, further 
demonstrating that the existing evidence is insufficient to determine what role, if any, 





 3.4.2 Studies of protein supplement timing relative to exercise 
The timing of protein supplementation appeared to influence body composition and 
muscle size, with no effect on strength. The individual study results indicated a 
possible effect on nitrogen balance, however the meta-analysis did not confirm this. 
There was disparity in the interventions used within this group, in terms of the type of 
the exercise component, the dose, source and timing of the protein supplements, and 
general characteristics such as the study duration. 
In a recent meta-analysis, Schoenfeld et al. (2013) considered the influence of 
protein ingestion timing in combination with RET in both older and younger adults 
[192]. Included studies implemented a RET programme of at least six weeks, and 
compared the effects of a protein supplement (≥6g EAA) given within two hours of 
exercise, with interventions in which no protein was consumed within two hours. No 
effects of protein timing on muscle strength or hypertrophy were reported. The study 
differs from the current review, as the lower age limit for classification as ‘older’ was 
just 50 years. Furthermore, rather than comparing alternative timing of a protein 
supplement, as in the current review, the comparison criterion in the Schoenfeld et al. 
review was the presence and absence of protein within two hours of exercise only, 
meaning not all interventions included any protein supplement. In fact, of the included 
studies involving older adults, all but one compared a protein supplemented group 
with a non-supplemented group, and in the remaining study participants had type II 
diabetes so would not have been eligible for inclusion in the current review. In the 
studies reported by Schoenfeld et al. it is feasible that the protein supplement itself 





Few studies were eligible for inclusion in the review, and the methodologies of the 
included studies were highly variable, giving few opportunities for comparison. 
Further to this, even within similar studies there were very few comparable outcome 
measures. As a result, a meta-analysis was only possible on one outcome from two 
studies. Furthermore, all included studies were categorised as high risk of bias. Thus, 
the conclusions drawn from this review must be tentative, and be used to identify 
knowledge gaps to be addressed by future research. 
3.4.4 Conclusions 
This review has identified very low quality evidence for an influence of timing and 
distribution of protein intake on selected outcomes of skeletal muscle function in 
older people [193]. However, no further conclusions or consensus can currently be 
drawn as to how to manipulate these factors to optimise the maintenance of muscle 
mass and function with age. 
It would appear from the distribution studies that some benefit to body composition, 
nitrogen balance and protein turnover may result from a daily Pulse distribution of 
protein, however there is reason to believe that further investigation with increased 
protein doses may produce a different result. Furthermore, the results require 
corroboration by additional intervention studies as these studies have no comparable 
outcome measures, and the addition of a control group to continue with their usual 
diet would determine whether these alternative distributions are superior to usual 
behaviour. In terms of the timing of a protein supplement relative to exercise, the 
current evidence is not sufficient to support any specific recommendation, and as 




4. OBSERVATIONAL STUDY: DIETARY PROTEIN INTAKE IN OLDER ADULTS; 
ADEQUATE DAILY INTAKE BUT POTENTIAL FOR IMPROVED DISTRIBUTION 
Aims: The development of sarcopenia may be influenced by the distribution of 
dietary protein across the day, and more specifically by the amount of protein per 
meal. The aims of this study were to characterise total protein intake in older adults, 
and to determine how it was distributed across the day. Secondary aims were to 
collect physical activity and sedentary behaviour data. 
Methods: 3-day food diaries recorded protein intake in 38 participants aged ≥70 
years. The quantity of protein in the diet was calculated, along with the pattern of 
distribution, the coefficient of variation (CV) for protein intake, and per meal protein 
content. Accelerometry was used to collect physical activity data, as well as the 
volume of sedentary time and patterns by which it was accumulated.  
Results: Average protein intake was 1.14 g·kg−1·day−1. Distribution was uneven 
(CV = 0.67), and 79% of participants reported <0.4 g·kg−1 protein content in at least 
two of their three daily meals. Protein intake was significantly correlated with step 
count (r = 0.439, p = 0.007) and negatively correlated with sedentary time (r = 
−0.456, p = 0.005) and Gini index G, which describes the pattern of accumulation of 
sedentary time (r = −0.421, p = 0.011). 
Conclusions: Total daily protein intake was sufficient; however, distribution did not 
align with the proposed ‘optimal’ intake pattern, nor was average total intake 
sufficient to reach the recommended per meal amounts; increasing protein intake 
may help to facilitate optimization of distribution. Associations between protein and 






 4.1.1 Rationale 
There are a number of factors which contribute to the development of sarcopenia, 
and among these are several aspects of lifestyle which have been identified as 
potential causes. These risk factors are modifiable, meaning they may be targets for 
intervention, and the characterisation of usual habits within the target population may 
inform the development of such interventions. 
As one of the main regulators of muscle protein synthesis, intake of dietary protein is 
one such lifestyle factor. While a great deal of attention has been given to the amount 
of protein required by older adults, there is also potential for the distribution of protein 
across the day to be manipulated to improve muscle health. An optimal protein 
distribution has been proposed, based on the observation that muscle protein 
synthesis (MPS) increases with protein dose up to a threshold intake, beyond which 
it plateaus. As discussed in Section 1.4.1, a relative value for this threshold has been 
calculated based on previous protein dose-response data; Moore et al. (2015) 
reported a threshold of 0.4 g.kg-1 for older adults, which is greater than the 0.24 g.kg-
1 threshold reported for younger adults [100]. It is recommended that protein should 
be spread evenly across the daily meals such that the protein content of each meal is 
sufficient to stimulate MPS to a maximal extent [54, 194]. As well as informing the 
specific pattern of protein intake, this would have consequences for total daily intake 
recommendations; in order to provide sufficient protein to reach 0.4 g.kg-1 per meal, 
total intake would need to be at least 1.2 g.kg-1.day-1. This would support the 
conclusion that older adults’ protein requirements are greater compared with those of 




the recommended daily allowance (RDA) of 0.8-1.2 g.kg-1.day-1 [117] and the PROT-
AGE recommendation of 1.0-1.2 g.kg-1.day-1 [119]. 
While experimental evidence of an effect of protein distribution is limited (Chapter 3), 
previous observations of typical dietary intake in older adults do suggest some effect. 
A recent analysis of data from the 1999-2002 National Health and Nutrition 
Examination Survey (NHANES), from men and women aged 50–85 years, reported 
greater lean mass and muscle strength in participants habitually consuming a higher 
frequency of meals containing at least 30 g of protein [134]. This cut-off of 30g 
respresents the threshold for maximal MPS when defined as an absolute amount; the 
relative threshold of 0.4 g.kg-1 has yet to be considered in an analysis of dietary 
intake. 
In addition to dietary protein, other modifiable lifestyle factors may influence muscle 
health. An association has been shown between low physical activity and low 
skeletal muscle mass index, which identifies low physical activity as a risk factor for 
declining muscle function and therefore a factor which may increase the progression 
of sarcopenia [195, 196]. Participation in physical activity is particularly low among 
older adults [197], which presents a strong potential target for intervention. Also 
associated with this is sedentary behaviour, which has often been presented as part 
of the problem of low physical activity, but is actually an independent issue. Defined 
as low energy activity (≤1.5 METS energy expenditure) in a seated or lying position, 
sedentary time is a risk factor for a range of health issues including sarcopenia [198]. 
The risks associated with sedentary behaviour are reflected in public health 
guidelines, which recommend minimising time spent sitting [199]. However, as with 




pattern of accumulation is also an important factor, and there appear to be health 
benefits to breaking up bouts of sedentary time [200]. With one study reporting total 
daily sedentary time of 17-18 hours in older adults [200], again this represents a 
substantial target for intervention. Along with dietary protein, physical activity and 
sedentary behaviour are modifiable lifestyle factors which can influence skeletal 
muscle in older age, and the identification of associations between these factors may 
be informative. 
 4.1.2 Aims 
The RDA does not currently specify a recommendation for per meal protein amount. 
As data relating to dietary protein distribution and how dietary habits align with the 
literature are lacking, it is not clear whether interventions are required to optimize 
protein distribution, and the design of interventions and recommendations is 
therefore limited. The primary aim of this study was to determine the total and per 
meal protein intake in a sample of older adults. Secondary aims were to objectively 
measure physical activity and sedentary behaviour within the same sample. 
4.2 Methods 
4.2.1 Recruitment 
Thirty-eight participants were recruited from July to November 2014. Recruitment 
took place through advertisements and meetings with local housing supported 
housing facilities and seniors’ groups, and information sent to members of the 
Birmingham 1000 Elders database of volunteers. To be eligible for inclusion, 




independently. This study was conducted in accordance with the Declaration of 
Helsinki and was approved by the ethics committee of the University of Birmingham. 
4.2.2 Data Collection 
Data collection consisted of two appointments separated by at least seven days, 
which took place in participants’ own homes. Instructions and materials were given 
as described below in the first appointment and collected in the follow-up 
appointment. Participant characteristics including age, sex and self-reported body 
weight were also collected during the first appointment; if body weight was unknown 
participants were asked to obtain a measurement in time for the follow-up meeting.  
Dietary intake was reported using 3-day food diaries, during which time participants 
were asked to maintain their usual diet. In the first appointment participants were 
provided with a standardised recording sheet and given both verbal and written 
instructions. They were required to complete the diary over three consecutive days 
including at least one weekend day, and were instructed to record details of all food 
and drink consumed, including the specific variety or brand of each item and any 
cooking methods used. The recording sheet also included a field to note the amount 
consumed, and participants were instructed to use weights and household measures 
where appropriate, or when necessary estimated portion sizes based on the 
guidance sheet provided. Diaries were reviewed during the second meeting, at which 
point participants provided verbal clarification or additional details when needed. 
Physical activity and sedentary behaviour were measured for seven days following 
the first appointment using ActivPAL3TM accelerometers. These monitors are able to 
collect postural as well as acceleration data, and can therefore determine whether 




periods to be classified as either standing, which is low-intensity but not defined as 
sedentary, or truly sedentary behaviour, as when sitting or lying down. Use of 
ActivPAL™ monitors been validated in terms of step count and active/sedentary time 
[201, 202]. 
Pre-programmed ActivPAL3TM monitors were attached to the anterior of the thigh 
during the first appointment using two 3M TegadermTM dressings to form a seal 
around the monitor. Participants were instructed to continue their normal daily 
routine, and to keep the monitor on throughout the monitoring period, including 
sleeping and showering, and to only remove it when bathing or swimming. Monitors 
were programmed to stop recording seven days after the first appointment, at which 
point they were removed. 
4.2.3 Nutritional Data Analysis 
Food diary data were entered into Dietplan6 software (Forestfield Ltd., West Sussex, 
UK, v6.70.73). Data were initially entered as whole days, and mean daily intakes of 
energy, macronutrients and micronutrients were calculated. Further data on protein 
intake were extracted from the software, including the percentage of total energy 
intake taken from protein, and the proportion of protein originating from plant and 
animal sources. Daily protein intake relative to body weight was also calculated 
(g·kg−1.day-1). 
The daily distribution of protein was determined according to the eating times 
recorded by participants. Each day was split into 30-minute timeslots between 05:00 
and 23:59, the protein intake for each slot was calculated and expressed relative to 
body weight, and the values for each slot were averaged across the three days. From 




examining patterns within the data. The periods were 05:00–11:00, 11:00–15:00, 
15:00-17:30, and 17:30–23:59, which encompassed all daily meals within the data 
(i.e. breakfast, lunch and dinner) and afternoon snack in the 15:00-17:30 period 
where applicable. By summing intake in each 30-minute timeslot within each period, 
per meal protein intake was calculated for each participant. Upon further examination 
it was clear that the 15:00-17:30 period containing afternoon snacks was not 
informative as protein content was negligible, and so the distribution was adjusted to 
three time periods to correspond to three daily meals; 05:00–11:00 (Period 1), 11:00–
16:00 (Period 2), and 16:00–23:59 (Period 3). Within these three daily meals, the 
main meal of the day was defined as a meal with the highest protein content; the 
period containing this meal was also identified for each participant.  
The per meal protein intakes were analysed relative to the proposed 0.4 g·kg−1 
threshold for maximal MPS [8]. For each time period the proportion of meals 
containing less than 0.4 g.kg-1 was calculated, and for each participant the average 
daily number of meals below the threshold was recorded (range 0-3). 
The average protein intakes for each time period were also used to examine the 
distribution of protein intake across the day, to determine whether protein intake was 
skewed or evenly distributed. This was quantified by calculating the coefficient of 
variance (CV) of protein distribution, as utilised in a previous study of dietary protein 
intake [133]. This dimensionless measure of distribution indicates evenness of intake 
across meals (CV = standard deviation/mean); a CV of zero would indicate the same 
amount in each period [133].  
Finally, protein distribution was defined according to the relative differences in protein 




categories, depending on whether there were differences in the amount of protein 
between meals, and which meals were larger. A threshold amount of 0.1 g·kg−1 
protein (approximately 10% of total intake) was used to define a difference between 
meals; for differences smaller than this, meals were classed as containing the same 
amount of protein. 
4.2.4 Physical Activity and Sedentary Data Analysis 
Activity data were downloaded from monitors using ActivPAL™ Analysis software 
(PAL Technologies Ltd., Glasgow, UK, v7.2.29). Only data from fully recorded days 
were used, and no attempt was made to remove sleep time (day or night) from 
sedentary data. Average daily step count, and volume of sedentary, standing and 
stepping time were extracted. 
Sedentary data from activity monitors were processed using MATLAB (The 
MathWorks Inc., Natick, MA, USA, vR2012b) [17] to calculate variables to describe 
the patterns of sedentary behaviour: (i) Weighted median sedentary bout length: 
when sedentary bouts were ordered from shortest to longest, the length of bout that 
contained the 50% point of accumulated sedentary time in each participant. Higher 
values indicate that sedentary time was accumulated predominantly in longer 
sedentary bouts [18]. (ii) Inter-sitting time: average difference between the start times 
of each two consecutive sedentary bouts, high values indicate either infrequent 
sitting down from standing or activity, or long periods of sitting with few transitions to 
standing. (iii) Fragmentation index: ratio of number of sedentary bouts to total 
sedentary time; high values indicate high fragmentation, suggesting accumulation of 
sedentary time in a large number of short bouts, as opposed to the longer, infrequent 




statistic used to measure inequality, with a range of 0–1, calculated by integration of 
the Lorentz curve [203]. A value of zero indicates that all sedentary bouts lengths 
contribute equally to sedentary time (i.e., a fragmented pattern), while a value close 
to one indicates a high level of inequality, meaning accumulation in a small 
proportion of long bouts. 
4.2.5 Statistical Analysis 
Sample size was determined by point estimate calculations based on measures of 
baseline protein intake from previous studies; a margin for error of 0.09 g.kg-1.day-1 
was deemed acceptable in the context of daily intake recommendations and feasible, 
and level of significance was 95%. Data were assessed using SPSS Statistics (IBM, 
New York, NY, USA, v23). Data were reported as mean (standard deviation). t-tests 
were used to identify differences between men and women and between participants 
living in supported housing and those not. Pearson’s correlation coefficients were 
calculated to assess associations between variables, and one-way ANOVAs were 
used to identify differences when participants were grouped by the number of daily 
meals containing less than 0.4 g·kg−1 of protein. Where assumptions of normality 
were not met, non-parametric tests were used. All tests were completed to a 95% 
significance level, and data are reported as mean (SD). 
 
4.3 Results 
Thirty-eight participants took part in the study (12 men, 26 women) and there was no 
dropout. Participant characteristics are displayed in Table 4.1. Of these, 36 provided 




the activity monitor, and for another there were technical issues when extracting data 
from the monitor. 
Table 4.1 also contains key variables for protein intake and activity data. All were 
normally distributed except percentage of energy from protein, step count, bout 
length and fragmentation index. Macronutrient intakes as a percentage of energy are 
in Figure 4.1. No significant differences were found between men and women for any 
variable.  
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Male (n (%)) 11 (30) 
Age (years) 78 (5) 
Body weight (kg) 68 (12) 
Dietary Intake 
Energy intake (kcal·day−1) 1815 (363) 
Protein intake (g·kg−1·day−1) 1.14 (0.25) 
Protein (energy %) 17.0 (3.4) 
Physical Activity and Sedentary Behaviour 
Step count (steps·day−1) 7136 (3276) 
Sedentary time (h·day−1) 18 (1.9) 
Standing time (h·day−1) 4.5 (1.5) 
Active time (h·day−1) 1.5 (0.6) 
Sedentary bout length (h) 1.6 (0.7) 
Inter-sitting time (h) 0.5 (0.1) 
Fragmentation index 3.1 (1.0) 
Gini index 0.75 (0.04) 
1Data are presented as mean (SD) unless otherwise stated. 
 
 
4.3.1 Protein Intake 
Average daily protein intake was 75.4 (12.3) g.day-1, or 1.14 (0.25) g·kg−1·day−1 when 
standardised by body weight. The RDA lower limit for protein intake of 0.8 
g·kg−1·day−1 was met or exceeded by 92% of participants [117], and the alternative 




The contributions of plants, meat and fish, and dairy sources of protein were 37 (8)%, 
42 (10)%, and 21 (7)% of total intake, respectively. 
Protein intake was not correlated with energy intake. Energy intake decreased 
significantly with age (r = −0.487, p = 0.002), and the negative correlation between 
age and protein intake approached significance (r = −0.304, p = 0.063). There was 
no significant difference according to whether participants lived in supported housing 
for any dietary intake variable. 
 4.3.1.1 Protein distribution 
The distribution of protein across the day was skewed; Periods 1, 2, and 3 contained 
18%, 39%, and 44% of daily protein respectively, and mean CV of protein distribution 
was 0.67 (0.20). This skew was even more pronounced when participants were 
grouped according to the period in which they consumed their main meal. For 15 
participants the main meal of the day was consumed during Period 2 (i.e. lunch), and 
their protein intake was distributed as 16%:55%:28% across the three time periods, 
and for the remaining 23 participants for whom Period 3 (i.e. dinner) contained the 
main meal, the distribution was 18%:27%:54%. There was no significant correlation 
between protein intake and CV of protein distribution. 
Daily protein intake patterns were categorised according the relationship between the 
amounts in each time period, as illustrated in Figure 4.1. Four categories were highly 
prevalent (1, 2, 5, and 7), accounting for 86% of the 114 included days. Common to 
all four of these categories was a small amount of protein at breakfast followed by a 
relatively larger lunch and/or dinner. It is also noteworthy that category 9, which 






Figure 4.2 Percentage of days in each category of protein intake pattern. Patterns are 
depicted above each bar, showing the relationship between the amounts consumed in 
Periods 1 (05:00–11:00), 2 (11:00–16:00), and 3 (16:00–23:59) in each category. A 
difference of 0.1 g·kg−1 protein between periods was required for them to be considered as 
different amounts. 
 4.3.1.2 Per meal protein amounts 
In relation to the 0.4 g·kg−1 threshold for maximal MPS, for Periods 1, 2, and 3 the 
proportions of participants meeting the threshold were 3%, 42%, and 68% 
respectively (Figure 4.2). On a participant level, no participant met the threshold in all 
three of their daily meals, 21% consumed two meals per day above the threshold, 
71% consumed just one meal above, and 8% did not reach the threshold in any of 
their three daily meals. One-way ANOVA comparing total daily protein intake in 
participants consuming below-threshold amounts for one, two, and three meals a day 
indicated a significant difference between groups (F(3, 35) = 6.112, p = 0.005). Post 
hoc analysis showed differences between one vs. three meals below (p = 0.004) and 
two vs. three meals below (p = 0.015); in both cases, intake was lower in the group 







Figure 4.3 Mean protein intake for each participant by time period (05:00–11:00, 11:00–
16:00, 16:00–23:59), bars represent mean for each period. Dashed line represents 0.4 
g·kg−1 threshold. * indicates significant differences between periods (p < 0.05). 
 
 
4.3.2 Physical Activity and Sedentary Behaviour 
Mean daily step count was 7136 (3276) steps·day−1. Daily sedentary time was 18.0 
(1.9) h·day−1, which equated to 75% of the time measured, with the remaining time 
divided into 19% standing and 6% stepping. For step count there was no significant 
difference according to gender or housing situation, and no correlation with body 
weight. There was a significant negative correlation between step count and age, (r = 




0.439, p = 0.007). There were significant differences between participants living in 
supported housing and those who did not, in terms of sedentary time (p = .033) and 
standing time (p = .039); mean daily sedentary time was 1.8 h.day-1 higher and 
standing time 1.3 h.day-1 lower in participants in supported housing. 
Variables describing the accumulation of sedentary time are presented in Table 1. 
Protein intake was significantly negatively correlated with sedentary time (r = −0.456, 
p = 0.005), and with the Gini index (r = −0.421, p = 0.011), indicating an association 
between low protein intake and a high volume of sedentary time accumulated in long 
bouts. 
4.4 Discussion 
The primary aims of this study were to determine total daily protein intake in adults 
aged 70 years and older, and to investigate how this daily intake was broken down 
into per meal amounts. The average protein intake in this sample was 1.14 
g·kg−1·day−1, which is a sufficient amount according to recommendations [117, 119]. 
However, per meal intake analysis showed that no participant consumed 0.4 g·kg−1 
of protein in all three meals of the day, indicating suboptimal protein distribution 
according to current literature. 
Data from the UK National Diet and Nutrition Survey (NDNS) reports a protein intake 
of 1.24 g·kg−1·day−1 for older adults [204], although the analysis included trimming to 
allow for underreporting, which may account for the lower value in the current study. 
Analysis from similar surveys conducted in the Netherlands reported intakes of 1.1 
g·kg−1·day−1 and 0.9 g·kg−1·day−1 in community dwelling adults aged over 65 years 
[170, 205]. For the majority of the participants in the current study protein intake was 




recommendation of 1.0–1.2 g·kg−1·day−1 [119], less than a quarter of participants had 
an intake which was below the lower limit. The proportion of energy obtained from 
protein was 17%, while the NDNS data indicated a value of 13.7% [204]; the current 
data were more similar to those of Tieland et al. (2015), which reported 16% of daily 
energy from protein in community-dwelling older adults [205]. This average value fell 
within the Acceptable Macronutrient Distribution Range (AMDR) recommended by 
the Institute of Medicine [206]. In addition to the quantity of protein, the proportions of 
intake derived from plant and animal sources were considered, and it was found that 
animal sources were the highest contributor to protein intake which is also consistent 
with NDNS data [207]. Protein source is an indicator of the quality of protein 
consumed; it has been demonstrated that the muscle protein synthetic response to 
soy protein is lower than that of various animal proteins [106, 115, 116], which is 
thought to be due to higher digestibility and a more favourable amino acid profile in 
animal proteins [112]. A dietary protein intake which tends towards a majority of 
animal-based proteins may therefore be considered beneficial. Hence, from the 
perspective of quantity and quality of dietary protein, it would appear that the dietary 
protein intake of this sample fell within the parameters which would promote muscle 
health. 
However, there is a body of evidence which suggests that it is not sufficient to 
consider just the amount of protein consumed, but that the way in which it is 
distributed across the day is also important for muscle health. In this sample, an 
average distribution pattern of 18:39:44% was calculated, indicating a skewed 
distribution. This became even more pronounced when calculated separately 
depending on the timing of the main meal of the day, revealing that over half of the 




was typically consumed at breakfast, both from the percentage split across the 
meals, and the intake pattern analysis illustrated in Figure 4.1. This pattern of 
particularly small amounts at breakfast is consistent with previous reports [170, 205]. 
This skewed nature of intake pattern was corroborated by a relatively high protein 
distribution CV of 0.67. Consistent with this, a previous study in community-dwelling 
adults aged ≥75 years reported a CV of 0.68 for non-frail participants [133]. A 
significant difference in CV between frail and non-frails participants was also 
reported, which is one indication of a potential effect of protein distribution on muscle 
health.  
Behind this proposed effect is the suggestion that per meal protein amounts may 
influence muscle accretion; this may explain the mechanism by which protein 
distribution influences muscle health. It is suggested that optimal MPS could be 
achieved by consuming a sufficient amount to reach the threshold for maximal MPS 
in each meal. Cross-sectional data for 50–85 year-olds extracted from the 1999–
2002 NHANES have shown that leg lean mass and strength are associated with the 
frequency of meals containing at least 30 g of protein [134]. This previous analysis 
was based on the estimates of the maximal MPS threshold dose given as absolute 
protein doses [60, 63], whereas the data in the present study were analysed in 
relation to the proposed threshold of 0.4 g.kg-1, given as protein dose relative to body 
weight [100]. From the present analysis it was found that at least two of the three 
daily meals contained less than 0.4g.kg-1 for 79% of participants, and no participant 
ate sufficient protein to reach the threshold in all three meals. Unsurprisingly, total 
protein intake was significantly lower in those participants who did not reach the 




between those achieving the threshold for either one or two meals. This concept of 
recommended per meal protein dose also impacts upon daily intake 
recommendations; to achieve three doses of 0.4 g·kg−1 in a day the diet would need 
to contain at least 1.2 g.kg-1.day-1, which sits at the higher end for both sets of 
recommendations; in this respect, the average total intake for this sample fell slightly 
short. As per the theory of optimal protein distribution, there is clearly potential for 
improvement in terms of protein distribution, as well as a need to increase total 
protein intake, to facilitate optimal of protein doses in line with this theory. 
As indicated by the findings of the systematic review in Chapter 3, existing 
experimental literature on protein distribution in older adults is scarce, however the 
results of the two chronic studies contradict this theory [182, 187]. Both studies 
reported greater improvements with a distribution skewed towards a lunchtime meal, 
rather than evenly spread protein doses. This may be explained by considering the 
amount of protein per meal as well as the overall distribution; in neither study did the 
doses in the Spread distribution reach 0.4 g·kg−1. Interventions to optimize protein 
distribution should manipulate per meal protein amounts in relation to data on acute 
responses. 
The basis of this distribution hypothesis is the saturable, dose-response relationship 
between protein dose and MPS response [60, 100]; however, the importance of this 
observation is contentious and not yet fully defined. The MPS response to a protein 
dose is only one part of the anabolic response, and the effect on muscle protein 
breakdown (MPB) also contributes to net muscle accretion. As well as stimulating 
MPS, the ingestion of protein also prompts a rise in insulin, which suppresses MPB 




meaning increasing protein doses may continue to bring about greater net gains of 
muscle protein [189]. On the other hand, even with continued suppression of MPB at 
higher protein intakes, a plateau in the MPS responsiveness would still alter the 
relationship between protein dose and net balance at doses beyond the threshold, 
which would impact upon the effects of protein distribution on muscle gains. This 
would again indicate an optimal distribution of three daily threshold protein doses. 
Due to the challenges associated with MPB measurement, focus in the literature 
tends towards measuring only MPS when studying anabolic responsiveness [189], 
meaning the MPB response is less well defined, particularly in a chronic setting. As 
described in Chapter 3, Kim et al. [190] compared three days of Even and Uneven 
protein distributions in older adults aged 52–75 years, and included outcome 
measures of whole body protein breakdown and net balance. This study reported no 
effect of protein distribution on either of these outcomes, however there was also no 
difference reported in MPS, which is inconsistent with previous studies [130, 182]. 
The effects of protein distribution on MPS, MPB, and net balance are still unclear; 
without further research, this remains a limitation of the protein distribution theory. 
A secondary objective of this study was to collect physical activity and sedentary 
behaviour data from the same sample. These are relevant measures to consider 
when looking at lifestyle factors in older adults, as both low physical activity and high 
sedentary time are additional risk factors for sarcopenia [195, 196, 198], and there 
are health benefits associated with fragmentation of sedentary time [208]. The 
average step count of 7136 step.day-1 was in line with results from a previous 
systematic review in older adults [209]. While public health recommendations for 
physical activity do not include step count targets, an analysis of existing data by 




moderate to vigorous physical activity into an estimated 7000-10000 steps.day-1 
[210]. As the average daily step count found in this study was just above the lower 
end of the range, it is not surprising that 58% of participants did not achieve 7000 
steps.day-1. Sedentary time accounted for 75% of the time studied, which is also 
similar to a previous study of physical activity and sedentary behaviour in older adults 
measured using ActivPALTM monitors [200]. Correlations with protein intake indicated 
that participants consuming less protein also had a lower step count and greater 
sedentary time, and that sedentary time was accumulated in longer bouts. 
Associations between these risk factors for sarcopenia are worthy of further 
investigation; the identification of clusters of unhealthy behaviour, or even causal 
relationships such as suppressed appetite caused by inactivity potentially resulting in 
low protein intake, may aid in the development of more effective interventions. 
The sample size in this study was relatively low compared to previous studies of 
dietary intake, which may be considered a limitation. However, point estimate 
calculations indicated that this sample size was sufficient to detect differences in 
protein intake. With respect to the method of data collection, the use of food diaries 
for dietary assessment in older adults has been validated [211], and the accuracy of 
3-day records is acceptable when compared with nine-day records [212]. 
Furthermore, the allocation of protein to just three meals in a day has previously 
been considered a limitation [133], however the data analysis in this study initially 
included an additional time period to allow for a snack, and the protein content of this 
period was negligible, indicating that it is valid to assess intake in three meals per 
day. This is the first study to assess per meal protein intake with respect to a 




terms, which is arguably more relevant to dietary recommendations, which are also 
given in this format.  
In conclusion, total protein intake was generally aligned with recommendations; 
however, per meal protein intake relative to body weight was suboptimal according to 
current literature. Intervention targets may include a focus upon an even distribution 
to achieve maximal MPS across the day, as well as increased total intake to facilitate 
optimal distribution. Additionally, lower protein intake was associated with lower 
physical activity and higher sedentary time, which may be further explored and 














5. INTERVENTION STUDY: INFLUENCE OF DIETARY PROTEIN DISTRIBUTION 
ON RESPONSIVENESS TO RESISTANCE EXERCISE TRAINING IN OLDER 
ADULTS 
Aims: To compare the effects of Pulse and Spread distributions of dietary protein, in 
combination with resistance exercise training (RET), on muscle protein synthesis 
(MPS) and muscle strength in women aged 65 years and older. 
Methods: Twelve older women (mean age 72.7 years) were recruited to this 2-week 
trial, and randomised and assigned to either Pulse or Spread groups. All participants 
followed a meal plan designed to provide 1.2 g.kg-1.day-1 protein, divided into either 
33:33:33% in the Spread group or 10:80:10% in the Pulse group, and all completed 
unilateral RET (knee-extension, 6 x 8 repetitions at 75% 1-repetition maximum (1-
RM), 3/week). Participants consumed 150ml D2O (70 atom %) on Day 0 and 50ml on 
Day 7. Body water enrichment was measured from saliva samples, vastus lateralis 
muscle biopsies on Days 0 and 14 were used to calculate myofibrillar MPS. Knee-
extension 1-RM tests were conducted at baseline and on Day 14 in trained (T) and 
untrained (UT) legs. Compliance with the study diets was monitored throughout. 
Results: Trained leg MPS was 1.02 (0.30) %.day-1 in the Spread group (n = 3) and 
1.16 (0.26) %.day-1 in the Pulse group (n=4). Corresponding values for the untrained 
leg were 1.05 (0.24) and 1.17 (0.29). There was no significant difference in MPS 
between distribution groups in either T (p = .75) or UT leg (p = .44), nor was there an 
overall difference between T and UT (p = .50). Strength increased by 28% in the T 
leg and 15% in the UT leg; change in strength was significantly greater with training 




Mean protein intake during the study was 1.21 g.kg-1.day-1, and compliance was 
90%. 
Conclusion: Dietary protein distribution had no effect on MPS or knee-extension 
strength over two weeks. 
5.1 Background 
 5.1.1 Rationale 
It is suggested that an even distribution of dietary protein is optimal for muscle health 
[54, 194]; this is not supported by the results of the systematic review in Chapter 3, 
however the reasons for the apparent benefits of an uneven distribution identified in 
those studies are still unclear, and with manipulation of dose sizes relative to the 
optimal dose threshold it is plausible that an even distribution may be advantageous.. 
The protein content of each meal should be equal to the threshold dose to stimulate 
maximal MPS, whether that be defined as an absolute amount of 30g or a relative 
dose of 0.4 g.kg-1. In this respect, the results of the observational study in Chapter 4 
indicate room for improvement within older adults’ dietary habits. While total daily 
intake was sufficient for most participants, intake was generally skewed rather than 
evenly distributed, and per meal protein content fell short of the threshold dose such 
that no participant reached the threshold in each daily meal. Hence, protein 
distribution is a prime target for intervention. 
The lack of experimental evidence in this area is clear from the findings of the 
systematic review in Chapter 3, in which only two studies of protein distribution in 
older adults were identified [182, 187]. These findings contradict the even distribution 




Kim et al. (2015, 2018), in which protein distribution had no significant effect on 
protein turnover in a 3-day study [190], or lean body mass (LBM), strength or 
functional ability in an 8-week study [191]. Hence, the role of protein distribution, and 
the mechanisms of action are still unclear. 
Furthermore, the effects of resistance exercise on muscle, and its blunted efficacy in 
older adults, are well known. In spite of this, there has been little research into the 
influence of dietary protein distribution on this response. Given that there is an 
interaction effect of protein and exercise in terms of acute responsiveness, it is 
plausible that this interaction may extend to exercise and protein distribution. 
Therefore, a 2-week intervention study into the efficacy of protein distribution and 
resistance exercise training (RET) in older adults was proposed. The protein 
distributions would be achieved by dietary manipulation, and the evenly spread 
distribution was designed to provide three daily doses of 0.4g.kg-1.day-1 as per the 
proposed optimal distribution [100]. The uneven distribution was based on the 
findings of the systematic review in Chapter 3 which reported greater improvements 
when approximately 80% of daily protein was consumed at lunchtime [182, 187]. 
RET would be unilateral lower limb exercise, to allow for comparison between trained 
and untrained legs as well as between the two parallel-design protein distribution 
groups. The study was to be single-sex, to avoid masking of any significant results by 
the different responses of older men and women to exercise [101]; women were 
chosen due to the greater loss of function experienced by women in older age [169]. 
Selected outcome measures would relate to muscle protein metabolism and muscle 
strength, with a 2-week duration selected as changes in outcomes would be 
expected over a short number of weeks [81, 82]. Meal plans were to be used to 




the meals, and compliance was to be used as an indicator of feasibility to inform the 
design of future studies. 
 
 5.1.2 Objectives 
The primary objective was to investigate the effects of dietary protein distribution on 
the rate of MPS, with and without RET, in older women over two weeks.  
Secondary objectives were as follows: 
 (i) Determine whether the effect of RET on muscle strength is influenced by protein 
distribution 
(ii) Investigate whether differences in MPS predict changes in muscle strength 
 (iii) Monitor participant compliance to meals plans, to consider the feasibility of this 
method of manipulating dietary protein distribution 
5.2 Methods 
 5.2.1 Study design 
Parallel study design comparing Pulse and Spread protein distributions with unilateral 
RET, with outcomes assessed at baseline and on Day 14 (Figure 5.1). 
5.2.2 Participants 
Participants were recruited between May 2016 and January 2018. Potential 
participants were identified from the Birmingham 1000 Elders database of volunteers, 
based on inclusion criteria; letters of invitation, along with a Participant Information 




participants completed a telephone health questionnaire to determine eligibility, and if 
eligible were invited to attend a pre-trial visit. 
Criteria for inclusion were; (i) Female; (ii) Aged ≥65 years; (iii) Ambulatory (with or 
without walking aids). Exclusion criteria were; (i) Already engaging in regular exercise 
(>1 per week); (ii) A selection of health criteria, listed in table 5.1, based on 
previously published criteria for exercise studies [213]; (iii) Treatment with 
anticoagulants or antiplatelets. This was a safety measure for muscle biopsies; an 
exception was made for participants taking a regular dose of aspirin, who were 


































Telephone health questionnaire 
Day 0 
Baseline measurement (MPS) 
Weeks 1-2 
Unilateral RET 




PULSE protein distribution 
10:80:10% 
Day 14 






Table 5.1 Exclusion criteria1 
.1 Based on previously published criteria for exercise studies [213]  
 
5.2.3 Pre-trial visit 
All study visits took place within the NIHR / Wellcome Trust Clinical Research Facility 
in the Queen Elizabeth Hospital, Birmingham. During the pre-trial visit, participants 
repeated the health questionnaire, blood pressure was measured, and the Mini 
Mental State Examination (MMSE) was completed. The eligibility criteria were 
applied, and if eligible, participants were recruited to the study. 
History of myocardial infarction within previous 2 years 
Cardiac illness: moderate/ severe aortic stenosis, acute pericarditis, acute myocarditis, aneurysm, severe 
angina, 
Clinically significant valvular disease, uncontrolled dysrhythmia, claudication within the previous 10 years 
Thrombophlebitis or pulmonary embolus within the previous 2 years 
History of cerebrovascular disease (CVA or TIA) within the previous 2 years 
Treatment with anticoagulants (Warfarin, rivaroxaban, apixaban, dabigatran) and antiplatelets 
(dipyridamole, clopidogrel, prasugrel, ticagrelor, glycoprotein IIb/IIIa antagonists). Nb. those regularly 
taking aspirin will be asked to stop for 3 days prior to biopsies and restart the day after 
Acute febrile illness within the previous 3 months 
Severe airflow obstruction 
Uncontrolled metabolic disease (e.g., thyroid disease or cancer) 
Significant emotional distress, psychotic illness or depression within the previous 2 years 
Lower limb fracture sustained within the previous 2 years; upper limb fracture within the previous 6 
months; non arthroscopic lower limb joint surgery within the previous 2 years 
Any reason for loss of mobility for greater than 1 week in the previous 2 months or greater than 2 weeks in 
the previous 6 months 
Resting systolic pressure >200 mmHg or resting diastolic pressure >100mmHg 
Poorly controlled atrial fibrillation 
Poor (chronic) pain control 
Moderate/ severe cognitive impairment (MMSE <23) 




Height and body weight were measured, and baseline strength measurements were 
taken; participants completed one-repetition maximum (1-RM) tests of knee-
extension on each leg. Participants were also given a food diary to complete as per 
the observational study in Chapter 4, and an ActivPALTM accelerometer to wear for 
seven days. 
Baseline food diary data were entered into Dietplan6 software (Forestfield Ltd., West 
Sussex, UK, v6.70.73). Protein and energy intake were extracted, daily protein intake 
relative to body weight was calculated (g·kg−1.day-1), and coefficient of variation (CV) 
for protein intake across the day was calculated as in Chapter 4. 
5.2.4 Dietary intervention 
Following the pre-trial visit, participants were assigned to either Pulse or Spread 
distribution groups; randomisation was completed by in advance by a University 
Hospitals Birmingham Statistician using a computer generated programme, and 
concealed in sequentially numbered opaque envelopes. 
Total daily protein intake was calculated for each participant based on body weight, 
and diets were designed to provide 1.2 g.kg-1.day-1. This was divided equally across 
breakfast, lunch and dinner for the Spread group, and in a 10:80:10% distribution for 
the Pulse group. Individual meals plans were customised for each participant using 
Dietplan6 software, according to their protein requirements and food preferences. 
Participants were provided with a meal plan consisting of 30 options containing the 
appropriate amount of protein for each of the three daily meals. Participants were 
free to choose from the selection of meals, in order to facilitate compliance, and 
prepared them themselves. Meal plans were composed of common foods, with the 




supplement was a commercial neutral tasting powder (Myprotein Milk Protein 
Smooth), derived from milk with a protein composition of 80% casein and 20% whey.  
 5.2.5 Exercise intervention 
Participants completed three sessions per week of knee-extension exercise. 
Sessions consisted of 6 x 8 repetitions, with an intensity of 75% 1-RM, calculated 
from the test completed in the pre-trial visit. Training was unilateral, using only the 
dominant leg. 
 5.2.6 Outcome measures 
 5.2.6.1 MPS 
The stable isotope tracer deuterated water (D2O) was used to measure the fractional 
synthesis rate (FSR) of myofibrillar proteins over the study period. Muscle biopsies 
were taken from the quadriceps vastus lateralis on Days 0 and 14 under local 
anaesthesia (1% lidocaine), using a 5mm Bergström needle. A single biopsy was 
taken from the non-exercised leg on Day 0, and samples from both legs were 
collected on Day 14. Samples were freed from visible fat and connective tissue and 
immediately frozen in liquid nitrogen, before storing at -80°C until further processing 
took place. 
Immediately following the biopsy on Day 0, participants provided a saliva sample, 
and drank 150ml D2O, as three doses of 50ml separated by 45 minutes (70 atom%; 
Sigma-Aldrich, Poole, UK). This split dosage was an effort to avoid the side effects of 
nausea and vertigo sometimes associated with D2O consumption. Three hours after 
the final dose of D2O participants provided a second saliva sample; for practical 




tube to take home along with instructions to record the time of the sample and to 
place it in the freezer until the next visit. 
Participants consumed a top-up dose of D2O on Day 7. Again, they provided an initial 
saliva sample, followed immediately by a single 50ml dose of D2O, and another 
saliva sample was taken at home three hours later. A final saliva sample was taken 
following the biopsies on Day 14. Participants were observed to ensure the D2O was 
consumed in its entirety. Saliva samples were centrifuged at 13000 RPM for 10 
minutes at 4°C to remove any debris, and the supernatant was stored at -20°C until 
further processing. 









Figure 5.2: Schematic of interventions and measurements 
 
  
















5.2.6.2 Muscle strength 
Knee-extension strength was measured using 1-RM. Baseline strength was 
measured during the pre-trial visit, and the second measurement on Day 14. Both 
trained and untrained legs were tested. 
 5.2.6.3 Protein intake and compliance 
To monitor adherence to the study diets, participants were provided with a standard 
compliance recording sheet. For each day they were asked to indicate whether they 
had consumed three whole meals from the plan, and to provide details of any 
leftovers or other deviations. Participants were made aware of the importance of 
adherence to study diets, and of reporting instances of non-compliance. To obtain 
more specific information on protein intake during the study period, participants also 
repeated the 3-day food diary during the second week of the diet. Food diary data 
were entered into Dietplan6 software, and total and per meal protein and energy 
intake were extracted. 
 5.2.7 Body water enrichment analysis 
Body water and muscle protein enrichment were measured according to published 
procedures [84]. Body water deuterium enrichment was determined from saliva 
samples. Samples were defrosted at room temperature, and 100μl placed in an 
autosampler cap before sealing with an inverted 2ml autosampler vial. Pure body 
water was extracted from the sample by heating at 100°C for 4h, and condensed by 




Samples were injected into a high-temperature conversion elemental analyser 
(Thermo Finnigan, Thermo Scientific, UK) connected to an isotope ratio mass 
spectrometer (Delta V Advantage, Thermo Scientific). 
 5.2.8 Muscle protein enrichment analysis 
In order to measure the incorporation of deuterium into protein-bound alanine in the 
myofibrillar muscle protein, samples were first separated into myofibrillar, 
sarcoplasmic and collagen fractions, and the amino acids released and derivatised 
as their n-methoxycarbonyl esters. Muscle samples were weighed and, where 
possible, 30-50mg muscle was taken for analysis, or when the sample weight was 
less than 30mg the whole sample was used. Sample were homogenised using 
scissors in 10μl.mg-1 ice-cold homogenisation buffer (50 mmol Tris-HCl, 50 mmol 
NaF, 10 mmol β-Glycerophosphate, 1 mmol EDTA, 1 mmol EGTA, 0.5 mmol 
activated Na3VO4 (Sigma-Aldrich, UK) with a complete protease inhibitor cocktail 
tablet (Roche, UK). The homogenate was rotated for 10 minutes before centrifuging 
for 5 minutes 13000g at 4°C, and the supernatant containing the sarcoplasmic 
fraction was removed. The pellet was solubilised in 0.3M NaOH and centrifuged, 
separating the solubilised myofibrillar fraction from the insoluble collagen, 1M 
perchloric acid was used to precipitate the myofibrillar protein fraction. The protein 
bound amino acids were released by cation exchange chromatography; firstly 0.1 
HCl and Dowex H+ were added and samples were incubated overnight. Amino acids 
were then eluted from the resin with NH4OH and dried down. To derivatise the amino 
acids, dried samples were resuspended in 60μl distilled water and 32μl methanol, 
vortexed, and 10μl pyridine and 8μl methyl chloroformate added. Samples were 
vortexed and left for 5 minutes at room temperature to react, before extraction into 




remove remaining water. Samples were transferred to autosampler vials, now ready 
for gas chromatography-pyrolysis-isotope ratio mass spectrometry to determine 
alanine deuterium incorporation. 
 5.2.9 Calculation of FSR 








where APEala = deuterium enrichment of protein-bound alanine, APEp = mean 
precursor enrichment over the time period, and t is the time between biopsies. 
Additionally, as protein synthesis tends to follow zero order kinetics, the fractional 
synthesis rate was also determined based on a single compartmental model by fitting 
a time course of net labelling to an exponential rise curve equation: 𝐸(𝑡) =
𝐸𝑚𝑎𝑥 × (1 − 𝑒−𝑘𝑡) where Emax is the number of hydrogens labeled (assuming 3.7) 
multiplied by the average body water labelling [78, 84]. 
 5.2.10 Data analysis 
Data were analysed using SPSS Statistics for Windows, Version 21.0. Armonk, NY: 
IBM Corp. Data are presented as mean (SD). All data were checked for normality, 
transformations attempted where necessary, and non-parametric tests used if data 
did not meet assumptions of normality and equal variances. Descriptive and baseline 
statistics were generated and 2-sample t-tests were used to detect differences 
between Pulse and Spread groups. Baseline knee-extension was tested for 
correlation with protein intake and CV of protein intake. For post data, as a measure 




intake from the target of 1.2g.kg-1.day-1. Any changes in protein or energy intake from 
pre-trial data were detected using paired t-tests, and differences between Pulse and 
Spread group using 2-sample t-tests. Paired t-tests detected differences between 
trained and untrained legs for FSR and change in knee-extension strength, as well as 
pre- to post- trial changes in strength, and 2-sample t-tests for differences between 
treatment groups. FSR and change in knee-extension strength were tested for 
correlation. 
5.3 Results 
 5.3.1 Participants 
Twelve participants were recruited to the study; two withdrew during the study for 
unrelated reasons, collection of MPS data for a further two was not possible due to 
failed muscle biopsies, and one participant completed the study and provided all 
samples but a signal could not be detected from muscle samples. Four participants 
experienced dizziness and nausea following D2O ingestion on Day 0, which has 
previously been reported as a side effect of D2O ingestion [71]. 
 5.3.2 Baseline data 
Baseline data are shown in Table 5.2. Overall mean age was 72.7 (4.6) years, and t-
test indicated a significant difference between the ages of Pulse and Spread 
distribution groups (p = .04). Average protein intake was 1.12 g.kg-1.day-1, which is 
consistent with the intake reported in Chapter 4, and daily distribution followed the 
same pattern of a lower protein content in the breakfast meal (Table 5.3). Neither 




protein intake was also calculated as in Chapter 4 to be 0.62 (0.18), with no 
significant difference between groups.  
Baseline knee-extension strength (Table 5.3) was greater in the Spread group than 
the Pulse group in the training (i.e. dominant) leg (p = .04) but not the untrained leg. 
Neither the strength of the training leg nor or the untrained leg was correlated with 
protein intake (p = .38; p = .61) or protein intake CV (p = .80; p = .25). 
 Total Spread group Pulse group 
N 12 7 5 
Age (years) 72.7 (4.6) 70.4 (3.7) 75.8 (4.1)1 
Height (cm) 161 (6) 161 (6) 162 (8) 
BW (kg) 64.5 (12.4) 69.1 (12.3) 58.1 (10.5) 
BMI (kg/m2) 24.9 26.8 22.2 
Protein intake 
(g.kg-1.day-1) 
1.12 (0.31) 1.26 (0.20) 1.00 (0.31) 
Energy intake 
(kcal) 
1750 (362) 1858 (254) 1698 (381) 
Protein CV 0.62 (0.18) 0.61 (0.26) 0.63 (0.12) 
Step count 7504 (2856) 5754 (1110) 8904 (3142) 
Table 5.2 Baseline data for all participants, means (SD). 1Significant difference between Spread and 
Pulse groups. 
 
 5.3.3 Protein intake 
Total daily protein and caloric intake did not change between the pre-trial and study 
period food diaries (p = .37; p = .37). Mean protein intake during the study period was 
1.21 (0.11) g.kg-1.day-1, divided into 1.21 (0.12) in the Spread group and 1.20 (0.11) 
in the Pulse group. The two groups consumed the same amount of protein (p = .85) 
and energy (p = .32). Meal plans were well adhered to in terms of the amount of 
protein consumed; a t-test indicated that daily intake was not significantly different 




were adhered to on 80% of days and 90% of meals within the study period; 
compliance did not differ between Pulse and Spread groups. 
The distribution of protein across the three daily meals is shown in Table 5.3. The 
Pulse group consumed the majority of their protein in the lunchtime meal as per the 
study diet, which accounted for a mean of 69 (16) % of their daily intakeThe Spread 
diet means were within 3% of the planned distribution percentages. 
 
 Breakfast Lunch Dinner 
Pre-trial (g.kg-1) 0.21 (0.09) 0.35 (0.17) 0.53 (0.16) 
Pre-trial (%) 18 (7) 36 (10) 46 (12) 
Trial period 
Spread group (g.kg-1) 0.37 (0.05) 0.46 (0.08) 0.38 (0.05) 
Spread group (%) 31 (3) 36 (6) 33 (6) 
Pulse group (g.kg-1) 0.17 (0.07) 0.82 (0.15) 0.21 (0.19) 
Spread group (%) 15 (6) 69 (16) 17 (14) 
Table 5.3 Per meal protein intake data from pre-trial and during trial 3-day food diaries, means (SD). 




MPS in the trained leg was 1.02 (0.30) %.day-1 in the Spread group (n = 3) and 1.16 
(0.26) %.day-1 in the Pulse group (n = 4), and 1.05 (0.24) %.day-1 and 1.17 (0.29) 
%.day-1 in the untrained leg. A paired t-test indicated no effect of training on MPS (p 
= .50). For both the trained and untrained legs, there was no difference in MPS 





Figure 5.3: FSR of myofibrillar MPS by distribution group in trained and untrained legs, means ± SD. 
Pulse group n = 4, Spread group n = 3 
 
5.3.5 Knee-extension strength 
Strength data for the trained leg in the Pulse group was not normally distributed and 
could not be rectified by transformation, so non-parametric tests were used. Knee-
extension strength increased from pre- to post- trial by 31 (14)% in the trained leg (p 
= .005), and by 18 (18)% in the untrained leg (p = .021) (Table 5.4). The change in 
strength was significantly greater in the trained leg (p = .019). Between the Pulse and 
Spread groups, there was no difference in either the post-trial knee-extension 
strength (trained p = .257; untrained p = .995), or in the pre- to post- trial change in 
strength (trained p = .999; untrained p = .862) (Figure 5.4). 
There were no significant correlations between MPS and change in knee-extension 































Table 5.4 Pre- and post-trial knee-extension 1-RM, means (SD) 
 Total Spread group Pulse group 
Pre-trial 
Trained leg 1RM (kg) 24.3 (6.7) 27.3 (7.5) 20.0 (0.9)1,2 
Untrained leg (kg) 21.0 (4.0) 21.6 (4.7) 20.3 (3.1) 
Post-trial 
Trained leg 1RM (kg) 30.4 (5.7) 32.5 (6.0) 27.2 (3.6) 
Untrained leg 1RM (kg) 24.4 (3.6) 24.4 (4.2) 24.4 (3.2) 
. 1Significant difference between Spread and Pulse groups. 2Assumption of equal variance not met, 









Figure 5.4: Knee-extension 1-RM strength as percentage change from baseline, by protein 
distribution group in trained and untrained legs, means ± SD. Pulse group n = 4, Spread group n = 6 
 
5.4 Discussion 
The primary aim of this study was to investigate the effects of dietary protein 
distribution on the muscle of older women in combination with unilateral RET, using 
D2O tracer techniques to measure the fractional synthesis rate of MPS over the 2-






















muscle strength over the same period, and to determine whether any changes in 
muscle strength could be predicted by MPS. Finally, the feasibility of manipulating 
dietary protein distribution in free-living participants was assessed on the basis of 
compliance with the study diets. 
 5.4.1 Effect of protein distribution 
FSR in the exercised leg was 1.16 and 1.02 %.day-1 in the Pulse and Spread groups 
respectively, with no effect of protein distribution. These are slightly lower than 
previous measurements; Brook et al. (2016) reported trained leg MPS of 1.49 %.day-
1 in older adults over three weeks [82], and Murphy et al. (2018) measured MPS in 
older adults undergoing RET with caloric restriction, reporting 1.52 %.day-1 with an 
uneven protein distribution and 1.64 %.day-1 with an even distribution [214]. Knee-
extension strength increased significantly over time, with greater increases in the 
exercise leg, however again there was also no difference with distribution. 
The basis of the hypothesised effect of protein distribution is repeated saturation of 
the dose-response relationship between protein and MPS [54, 194]. The 
experimental diets in this study were designed such that the Spread group were 
consuming 3 daily doses of 0.4 g.kg-1.day-1, the threshold dose for maximal MPS in 
older adults [100]. Hence, a higher FSR may have been expected in the Spread 
group; these findings do not support the hypothesis. 
Section 1.4.5 details acute evidence which indicates an effect of protein distribution 
on responsiveness of the muscle. In terms of results from comparable longer-term 
studies, as demonstrated by the systematic review in Chapter 3, evidence is limited 
with contradictory results to date. Similar findings to this study have been reported in 




3-day habituation to the study diets, Kim et al. (2015) reported no difference in MPS 
or whole-body protein kinetics from a 24-hour stable isotope tracer infusion trial [190]. 
When the same distributions were applied as an 8-week intervention, results were 
the same for protein metabolism, and similarly there was no effect on body 
composition, muscle strength or functional measures [191]. However there is also 
evidence which does support the spread distribution hypothesis. Mamerow et al. 
(2014) reported a greater MPS response with evenly distributed doses compared 
with a skewed intake (11:17:72%), although this was in younger adults [130]. In older 
adults, a 4-meal spread distribution of 1.3g.kg-1.day-1 has been shown to an increase 
MPS to a greater extent than a skewed distribution, an effect which increased with 
exercise [215]. However, this was under conditions of dietary energy restriction, and 
a 13-hour infusion trial conducted during energy balance within the same study found 
no effect. This was attributed to the energy restriction, although an increase in protein 
intake from 1.0 g.kg-1.day-1 to 1.3 g.kg-1.day-1 between the energy balance and 
restriction trials may also have been a factor. Finally, there is also evidence which 
suggests greater benefits of a skewed distribution. The two distribution studies 
included in the systematic review in Chapter 3 reported greater improvements in 
body composition, protein retention, and nitrogen balance, with distributions skewed 
towards the lunchtime meal which contained approximately 80% of daily protein [182, 
187]. 
Evidence of an influence of protein distribution on MPS and longer-term indicators of 
muscle health is contradictory. The findings of this study support a lack of influence 
of distribution on responsiveness to protein intake, in spite of the target doses for the 
Spread group being equal to the threshold dose of 0.4g.kg-1, and only a small amount 




These were determined according to previous studies of acute responsiveness to 
isolated doses; Moore et al. (2015) included data from 6 studies, all of which used 
supplements of high quality animal protein [100]. Protein sources in the study diets 
were more varied, and given the influence of protein source on the muscle protein 
synthetic response [106, 115, 116], the inclusion of lower quality proteins in the study 
diet would increase the protein dose required to reach maximal MPS. The use of 
isolated protein in acute studies is also significant, as in the context of dietary intake 
it is more likely that protein would be consumed as part of a mixed meal. Other 
nutrients consumed in proximity to protein ingestion may interact with the effects of 
protein. In particular, carbohydrate stimulates the release of insulin, which influences 
net muscle protein balance by suppressing muscle protein breakdown [37]. Some of 
the existing literature is consistent with this notion that higher protein doses than the 
identified maximal MPS threshold may be required to overcome the effects of a 
mixed meal intake. For example, the even distribution used by Mamerow et al. (2014) 
provided approximately 0.41g.kg-1 in each meal, however this was a study in younger 
adults [130]. At 70% above the threshold of 0.24g.kg-1 calculated in younger adults 
[100], this dose is more likely to be sufficient to stimulate maximal MPS even with the 
potential effects of lower protein quality and co-ingestion with other nutrients. 
Furthermore, as described above a previous study of energy restriction has shown 
greater MPS with an even compared with a skewed distribution [215]. A recently 
published study implemented the same distribution interventions over 2-week periods 
using D2O to measure MPS throughout, and reported a conflicting result suggesting 
no effect of distribution [214]. One key difference between the studies was that, 
during the infusion protocols used to measure MPS in the prior study, protein doses 




consumed as mixed meals. This provides a potential explanation for the disparity in 
responsiveness between the two results. 
The discrepancy between the trials included in the Chapter 3 systematic review, and 
the lack of effect found here, is difficult to explain. It may be noteworthy that at 
approximately 80% of daily protein, the large Pulse dose in these studies was greater 
than in any of the other distribution studies mentioned previously [182, 187]. A 
proposed explanation for the apparent benefits of the Pulse distribution in these 
studies is the influence of protein distribution on EAA bioavailability. One of the 
potential causes of anabolic resistance to protein ingestion is differences in 
splanchnic sequestration of essential amino acids (EAAs) in response to feeding, as 
greater retention of EAAs by the gut and liver can reduce the increase in plasma EAA 
concentrations, and therefore bioavailability for MPS. Splanchnic sequestration of 
EAAs increases with ageing; specifically leucine extraction was found to be twice as 
high in older men as younger men, and was inversely related to plasma leucine 
concentrations following feeding [188]. Older adults have also shown greater 
phenylalanine sequestration [216]. Leucine bioavailability is of a particular concern, 
given its ability to stimulate MPS above that of other EAAs [217, 218], and its 
signalling role in the mTOR pathway [48, 108]. It has also been shown that this 
process of splanchnic sequestration is saturable in response to high protein doses 
[219]. Bouillanne et al. (2013) suggest that the Pulse dose reached this saturation 
point; a separate paper reporting plasma EAA concentrations in response to the two 
protein distributions noted an increase in leucine concentration of 101% above 
baseline in the Pulse group, compared with 51% in the Spread group [220]. This 
effect persisted after 6 weeks of the intervention, and is proposed as the mechanism 




explain the conflict in the results of the current study; total daily protein intake was 
1.5g.kg-1.day-1 compared with 1.2g.kg-1.day-1 in the current study. Therefore the large 
Pulse dose would have been considerably higher in comparison to the current study, 
and the Pulse dose used here may not have been sufficient to have the same effect. 
5.4.2 Effect of exercise 
This study employed a unilateral RET model, meaning that the influence of diet could 
be assessed both with and without exercise for measures of MPS and knee-
extension strength. This is the first study of dietary protein distribution in older adults 
to introduce an exercise component without accompanying energy restriction; the 
lack of significant effects in both trained and untrained legs indicates the same 
influence of protein distribution with and without exercise. An increase in 1-RM knee-
extension strength of 28% in the trained leg was significantly greater than that which 
measured in the untrained leg, which was to be expected given the known effects of 
RET on muscle strength [95, 96]. However, this was not accompanied by any 
difference in MPS in response to training. It has previously been shown that the 
acute responsiveness to resistance exercise is subject to anabolic resistance in older 
muscle [56], and it appears that longer term MPS is also blunted in older age. Brook 
et al. (2016) conducted a study with a similar training protocol in both younger and 
older adults, with measurements at 3 and 6 weeks [82]. As in the current study, the 
D2O tracer was used to measure MPS over the study duration, and strength was 
measured as knee-extension 1-RM. While both groups displayed increases in 1-RM 
with training, an increase in MPS over that of the untrained leg was observed only in 
the younger group. This was accompanied by blunted anabolic signalling in the older 
group. This apparent anabolic resistance is consistent with the lack of effect of 




the absence of any difference in MPS, is that the observed increase in strength was 
actually a result of improved coordination as a result of training. Rutherford and 
Jones (1986) concluded that improvements in performance in strength tests were, in 
part, due to improved ability to coordinate other muscle groups [221]. Given that the 
improvements in the present study were observed over a relatively short period of 
time, this may be a plausible explanation for these results. 
5.4.3 Feasibility of intervention 
Another aim of the study was to assess the feasibility of manipulating dietary protein 
distribution in free-living participants using personalised meal plans. Participants 
prepared their own food at home in accordance with the plans, while in most previous 
distribution studies participants been provided with pre-prepared meals to be 
consumed either on-site or at home [130, 182, 190, 191, 215], or were hospital 
inpatients and so received meals from the hospital kitchen [187]. Distribution studies 
have so far been of a relatively short duration, however with a view to longer-term 
studies, meal plans may present a more practical method. The meal plans in this 
study were designed to promote participant compliance, by including a variety of 
foods, allowing certain amount of choice, and by asking participants to record 
adherence. This was informed by previous studies of high protein/carbohydrate and 
heart-healthy diets, which included these elements to increase compliance [222, 
223]. A high compliance of 90% of individual meals indicates that, over a 2-week 
period, this method of manipulating protein distribution is feasible, and this may be 
considered in the design of future studies. The greatest deviation in protein intake 
from the planed distribution was seen in the large lunchtime Pulse dose. The timing 
of the large dose was based on previous studies [182, 187], however in other studies 




this and the observational data in Chapter 4 indicate a tendency for the evening meal 
to contain the most protein, hence a distribution study may see higher compliance by 
moving the large Pulse accordingly.  
One existing study has used D2O methodology to measure MPS throughout a protein 
distribution study in older adults [214]. However, this previous study involved obese 
older men under conditions of energy restriction, which is thought to potentially 
accelerate loss of muscle as well as adiposity during weight reduction [224]. This is 
the first study to implement this technique when examining the effect of protein 
distribution in the absence of a deliberate weight loss element. MPS is included as an 
outcome measure in a number of distribution studies described above, but these 
have generally used stable isotope tracer infusion protocols to measure acute 
responsiveness over a 12-24-hour period at the start and end of a of the distribution 
intervention [130, 190, 191, 215]. Insights gained from such methods are limited, in 
that they can inform how the intervention may affect acute responsiveness, but not 
how protein metabolism may be altered during the intervention. Given that the theory 
in favour of a Spread distribution is based upon generating greater MPS across each 
day compared to the Pulse distribution, the daily rate of MPS during the study period 
is an important outcome in understanding the effects of protein distribution. Unlike 
the more invasive tracer infusion protocol, the D2O method allows measurement of 
MPS in a free-living situation. While this does introduce an uncontrolled behavioural 
element to the study as a potential source of variation, it does make the results more 







The conclusions of this study are limited by the small sample size and increased 
chance of Type II error, and the lack of significant distribution effects may therefore 
be a product of sample size. This was largely due to delays and time constraints, and 
the relatively small initial sample size was compounded by a high rate of attrition. 
Attrition consisted of participants who withdrew for unrelated reasons, and those for 
whom there were difficulties obtaining viable muscle samples, potentially due to age-
related changes in muscle composition, such as increased fatty infiltration [1, 225]. 
 5.4.5 Conclusions 
In conclusion, in a comparison of Pulse and Spread distributions in women aged 65 
years and older, there was no significant effect of distribution pattern on MPS over 
two weeks, nor was there a difference in strength between the distribution groups. 
Compliance to the study diets was high, indicating individual meal plans are feasible 











6. SUMMARY AND GENERAL DISCUSSION 
The development of interventions to protect against sarcopenia in older age is an 
important research goal, however the role which dietary protein may play in such 
interventions is unclear. Data from acute studies is promising with regards to 
increasing MPS, however this has yet to translate into any definitive conclusion on a 
protein-based intervention which consistently influences older muscle in a chronic 
setting, i.e. across more than a single day. The aim of the studies reported in this 
thesis was to contribute to this ongoing goal by identifying areas for improved 
efficacy of dietary protein; this was to be achieved by reviewing several aspects of 
the existing literature, assessing typical protein intake in a sample of older adults, 
and with the development and implementation of an intervention study based on 
these findings. 
6.1 Summary of findings 
 6.1.1 Chapter 2: Protein supplementation and RET 
Systematic literature searches identified 15 studies in adults aged 70 years and older 
comparing the effects of RET with and without protein supplementation on muscle 
strength and size, functional ability, or body composition. The main finding of the 
review was that, while improvements were seen with exercise in in each of these 
categories in the majority of studies, there were no additional effects with 
supplementation. This is a significant departure from the conclusions of previous 
systematic reviews evaluating these interventions; Cermak et al. (2012) and Finger et 
al. (2015) both identified significant additive effects of RET and protein 
supplementation in older adults, with regard to body composition and muscle 




and previous reviews is the age of participants in the included studies, which may be 
the cause of this discrepancy. With mean participant age in each study set at a 
minimum of 70 years, the youngest participants included in this review were 60 years 
old; this is higher than the previous reviews, and a plausible reason for the differing 
results. Hence, these findings can be said to be more truly representative of older 
adults than any previous reviews. In contrast to the effects seen in younger adults 
[140], it would appear that supplementing RET with protein is not likely to be an 
effective intervention to combat protect against sarcopenia, assuming total daily 
intake meets minimum requirements. 
 6.1.2 Chapter 3: Protein intake pattern 
This second systematic review demonstrated that chronic studies investigating the 
effects of protein timing and distribution in older adults are relatively scarce. A dearth 
of data was anticipated when designing the search strategy, and indeed only six 
relevant studies were identified. Of these, two provided a comparison of different 
distributions of dietary protein across the day [182, 187]. Both studies compared a 
relatively even spread of protein over the daily meals (Spread), with distributions 
containing one large bolus of protein in the lunchtime meal and small amounts in 
other meals (Pulse). Both studies reported some significant differences between the 
groups (body composition, nitrogen balance, protein turnover), and interestingly it 
was consistently the Pulse distribution which produced the superior results. This is a 
significant finding, as it contradicts suggestions based on acute responsiveness data 
that an even protein distribution may have more beneficial results [54, 194]. This 
review indicated the need for future research into this area. Furthermore, as these 
results contradict hypotheses generated from the acute data, further investigation 




results from the current thinking. The methodologies of these studies also provided 
the basis of the protein distributions to be used in a new intervention study reported 
in Chapter 5, for the purposes of comparability. 
 6.1.3 Chapter 4: Typical dietary habits of older adults 
Food diary and physical activity data were collected from 38 participants aged 70 
years and above. Total daily protein intake was 1.14 g.kg-1.day-1, and 92% of 
participants were consuming sufficient protein to exceed the RDA lower limit of 0.8 
g.kg-1.day-1, while 76% were meeting the higher recommendation of 1.0 g.kg-1.day-1 
[117, 119]. Distribution across the day was uneven, with a split of 18:39:44% across 
breakfast, lunch and dinner, and per meal protein intake reached the maximal MPS 
threshold of 0.4 g.kg-1 [100] by 3%, 42% and 68% of participants in each of these 
meals. Few studies have previously recorded typical per meal protein amounts as 
well as the total intake in older adults, and this is the first to analyse these data 
relative to the 0.4 g.kg-1 threshold. Although total protein intake was sufficient for 
most participants according to recommendations, with regard to the theory of optimal 
MPS stimulation by reaching the threshold dose in every meal, there is clear room for 
improvement as no participant consumed amounts above the threshold in all three 
daily meals, and the threshold was rarely reached in breakfast meals. These results 
informed the design of a protein distribution intervention study, identifying a potential 
target for intervention in the form of per meal protein amounts, and also by providing 
information used in the design of future meal plans. 
 6.1.4 Chapter 5: dietary protein distribution and RET intervention study 
A protocol was developed based on the findings of the systematic review and 




distribution on responsiveness to RET in women aged 65 years and older. For the 
primary outcome of MPS, measured over the two-week intervention period, there was 
no difference between Pulse and Spread protein distribution groups. This was also 
the case for 1-RM knee-extension strength, which increased by the same amount in 
both distribution groups. This is the first study to design the per meal protein doses 
around the proposed threshold of 0.4 g.kg-1.day-1, in order to stimulate maximal MPS 
three times daily in the Spread group. The distributions were also chosen to be 
consistent with those used by the studies included in the systematic review to allow 
comparability, albeit slightly altered with respect to the threshold. In spite of this, 
however, the results neither supported the spread protein distribution theory, nor 
were consistent with previous results of a superior Pulse distribution as per Chapter 
3, indicating no effect of protein distribution. The results are, however, similar to a 
very recent study of protein distribution conducted using D2O to measure MPS, this 
time in older men under conditions of energy restriction [214]. During two weeks of 
protein distribution intervention only, followed by two weeks of distribution with RET 
intervention with RET, Murphy et al. (2018) found no difference in myofibrillar MPS 
between distribution groups [214]. A previous study from the same group 
implemented the same interventions, but measuring MPS before and after 
intervention using an acute tracer infusion protocol, reported a contrasting result with 
greater MPS in the Spread group [215]. One potential explanation for this 
discrepancy is the meal composition; in the earlier study isolated protein was given 
during the infusion trials, whereas measurement with D2O throughout the study 
meant that protein was consumed as mixed-nutrient meals as part of the diet, which 
may alter anabolic responsiveness. This is also proposed as an explanation for the 




stimulate maximal MPS based on a threshold calculated using isolated, high quality 
protein. The threshold may be altered by an altered anabolic response due to co-
ingestion with other nutrients, hence it is plausible that doses were too low to 
maximally stimulate MPS in this context. While the mechanism remains unclear, a 
key finding of this study is that three daily meals containing 0.4 g.kg-1 protein do not 
significantly increase MPS over the response to a Pulse distribution, although with 
the caveat that the study was possibly underpowered due to a small sample size. 
 6.2 Implications of the findings 
This research has implications for dietary recommendations for older adults. Based 
on previous evidence, older adults undertaking RET may have been recommended a 
protein supplement to increase the improvements in body composition and muscle 
size and function, when in fact there appears that this would not have any effect 
when total protein intake is otherwise sufficient. There has also been some 
suggestion that, as well as consuming sufficient protein to meet the RDA, older 
adults should consider spreading their protein intake evenly across daily meals. The 
evidence for this is mixed at best, and while the intervention study found no effect of 
distribution, the systematic review actually found in favour of skewing intake towards 
one large meal. Hence, a particular daily distribution should not be recommended at 
present. 
Observational data indicate an average daily protein intake which meets 
recommendations, however this was not universal to all participants, especially with 
regard to the higher recommended minimum intake of 1.0 g.kg-1.day-1 which 24% of 
participants failed to reach. This indicates that total protein intake is still a problem 




based on these data. Firstly, intake patterns show that breakfast typically included 
the lowest protein content of the day, which is consistent with previous observations 
[170, 205]. Hence, a focus upon increasing breakfast protein content specifically may 
be an effective strategy for increasing daily intake. The data also indicate an 
association between lower protein intake and higher sedentary time accumulated 
over a few long bouts. The identification of this cluster of behaviours likely to impact 
muscle health may be useful in the design of interventions to combat sarcopenia; for 
example, interventions to reduce sedentary time, and therefore increase energy 
expenditure, may help to overcome the reduced appetite which often leads to protein 
deficiency in older age [226]. 
 6.3 Future research 
The effects of dietary protein distribution on older muscle remain unclear. The results 
reported in this thesis indicate no effect, although results have been reported in 
favour of both Spread and Pulse style distributions. Further research is required to 
determine whether distribution may be manipulated to counter sarcopenia, and to 
explain the range of results reported by previous studies. 
In terms of preliminary work, the 0.4 g.kg-1 threshold was used here as the basis of 
the Spread distribution design, however this was calculated from data collected from 
older men [100]. Given the differences in protein metabolism between men and 
women [101, 227], it may be that this value differs in older women; thresholds have 
yet to be calculated using female data. 
When investigating the influence of protein distribution on older muscle, there are two 
types of outcome to consider; the mechanistic measures such as MPS, and the more 




addressing the problems of sarcopenia which are faced by older adults. Integration of 
these outcomes within the same study is difficult, as changes in the fractional 
synthesis rate of myofibrillar muscle proteins tend to occur over a relatively short 
duration [82], whereas a longer period of intervention is required to detect clinically 
relevant changes in other outcomes such as body composition and muscle function. 
A proposed study design to address this problem is shown in Figure 6.1. The 
protocol is divided into two parts; Part 1 is essentially similar to the study protocol of 
the Chapter 5 study, using D2O to measure muscle protein synthesis with unilateral 
RET over two weeks. Part 2 is of a longer duration, suggested 10 weeks, and is 
designed to measure those outcomes which would respond to a chronic intervention. 
The same study diets would continue throughout both parts of the trial, but in Part 2 
unilateral RET would be replaced with whole-body resistance exercises. The two 
parts are designed to run consecutively without interruption rather than as standalone 
studies, providing the opportunity to investigate any associations between short- and 
long-term differences, and therefore whether changes in MPS may influence the 
chronic outcomes.  
As shown in Chapter 5, dietary compliance results indicate that meal plans 
implemented by participants are an effective method of manipulating protein 
distribution over two weeks. They may therefore be considered for use in future 






















Figure 6.1: Summary of proposed trial design for integrated measurement of mechanistic and 
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It is likely that the responsiveness to a distribution is determined by the actual 
amount of protein in each dose. As has been alluded to in previous sections, it is 
possible that the protein doses used in distribution research so far have been 
insufficient in size. Bearing in mind the maximal MPS threshold dose of 0.4 g.kg-1, the 
theory that a distribution in which every meal reaches this threshold has not been 
tested in many of the existing distribution studies, due to the tendency to split even 
distributions into four meals [182, 187, 214, 215]. Results from Chapter 5 indicate no 
effect even with the Spread diet designed around this threshold; one potential 
explanation is that the dose sizes were still insufficient as a result of altered 
responsiveness due to variable protein quality and co-ingestion with other nutrients. 
Hence, when designing future studies a higher total protein intake may be 
considered, although defining a specific threshold is more complex in the context of 
meals rather than isolated protein due to the number of different variables. 
Chronic outcome measures may be similar to those identified in the systematic 
review in Chapter 2. Body composition measures are relevant, as loss of lean body 
mass is one of the key characteristics of sarcopenia, as well as muscle power, which 
declines with ageing and affects functionality [27, 169]. When considering the impact 
of this intervention on the lives of older adults, arguably the most important outcomes 
are measures of functional ability. For example, the Short Physical Performance 
Battery (SPPB) consists of three tests (balance, walking speed, and chair rise ability); 
scores have been shown to correspond to self-reported levels of disability in older 
participants [164] and it is an outcome measure recommended by the EWGSOP for 
use in studies involving older adults [228]. The timed up and go (TUG) test has been 




Additionally, there may be benefits to the inclusion of plasma AA concentration as an 
outcome measure. One of the studies which did report an effect of protein 
distribution, in favour of the Pulse pattern, attributes this to saturation of splanchnic 
sequestration by the large protein dose only, leading to greater EAA bioavailability as 
indicated by plasma concentrations [187, 220]. Measurement of plasma AA 
concentrations during a future distribution would enable further comparisons with 
previous results, and may help to reconcile the wide variety of responses protein 
distribution reported in older adults. 
The most appropriate measure of MPS in this context is using D2O tracer 
methodology over a period of multiple days [84]. However, in the Chapter 5 study this 
technique was not without its problems, namely the nausea and vertigo experienced 
by some participants which led to substantial delays. This is a known side effect 
which can usually be mitigated by dividing into smaller, spread-out doses [71]. This 
incidence of reactions in this study is difficult to explain, as doses were appropriately 
space to minimise the chance of side effects, and anecdotal reports and published 
papers from studies using the technique indicate that reactions are not common. 
Robinson et al. (2011) reported a slight dizziness in the participant with the lowest 
body weight [77], however here there was no distinguishing characteristic of the 
participants who experienced a reaction. This would need to be a consideration when 
designing future studies, particularly when planning recruitment and timelines, to 
account for the consequent withdrawals. 
 6.4 Conclusions 
Loss of muscle mass and function is a significant problem in older age, and dietary 




health and attenuate this decline. However, there appears to be no augmentation of 
RET benefits with protein supplementation, and evidence of an effect of daily dietary 
protein distribution is mixed at best. Even when distributions are designed for optimal 
MPS according to an acute data theory, MPS was not influenced by protein 
distribution. There is currently no basis to alter dietary protein recommendations to 
include a suggested distribution or per meal dose size, however there is still scope 
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